Datasets:

Modalities:
Text
Formats:
parquet
Libraries:
Datasets
pandas
License:
LionelLow commited on
Commit
9e3083d
·
verified ·
1 Parent(s): 4240a2e

Uploading O notated Conll files

Browse files
PLOD-CW-25-Test.conll ADDED
The diff for this file is too large to render. See raw diff
 
PLOD-CW-25-Train.conll ADDED
The diff for this file is too large to render. See raw diff
 
PLOD-CW-25-Val.conll ADDED
@@ -0,0 +1,6154 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ Multi ADJ B-LF
2
+ - PUNCT I-LF
3
+ locus ADJ I-LF
4
+ sequence NOUN I-LF
5
+ typing NOUN I-LF
6
+ ( PUNCT O
7
+ MLST NOUN B-AC
8
+ ) PUNCT O
9
+ was AUX O
10
+ performed VERB O
11
+ by ADP O
12
+ PCR NOUN B-AC
13
+ - PUNCT O
14
+ sequencing NOUN O
15
+ of ADP O
16
+ a DET O
17
+ set NOUN O
18
+ of ADP O
19
+ pneumococcal ADJ O
20
+ housekeeping NOUN O
21
+ genes NOUN O
22
+ , PUNCT O
23
+ including VERB O
24
+ ardE NOUN O
25
+ , PUNCT O
26
+ gdh NOUN O
27
+ , PUNCT O
28
+ gki NOUN O
29
+ , PUNCT O
30
+ recP NOUN O
31
+ , PUNCT O
32
+ spi NOUN O
33
+ , PUNCT O
34
+ xpt NOUN O
35
+ , PUNCT O
36
+ and CCONJ O
37
+ ddl NOUN O
38
+ [ PUNCT O
39
+ 17 NUM O
40
+ ] PUNCT O
41
+ . PUNCT O
42
+
43
+ The DET O
44
+ investigated VERB O
45
+ traits NOUN O
46
+ were AUX O
47
+ heading NOUN B-LF
48
+ date NOUN I-LF
49
+ ( PUNCT O
50
+ HD PROPN B-AC
51
+ ) PUNCT O
52
+ , PUNCT O
53
+ plant NOUN B-LF
54
+ height NOUN I-LF
55
+ ( PUNCT O
56
+ PH PROPN B-AC
57
+ ) PUNCT O
58
+ , PUNCT O
59
+ GY PROPN B-AC
60
+ , PUNCT O
61
+ thousand NUM B-LF
62
+ grain NOUN I-LF
63
+ weight NOUN I-LF
64
+ ( PUNCT O
65
+ TGW PROPN B-AC
66
+ ) PUNCT O
67
+ , PUNCT O
68
+ weight NOUN O
69
+ of ADP O
70
+ straw NOUN O
71
+ – PUNCT O
72
+ referred VERB O
73
+ to ADP O
74
+ as ADP O
75
+ straw NOUN B-LF
76
+ yield NOUN I-LF
77
+ ( PUNCT O
78
+ SY PROPN B-AC
79
+ ) PUNCT O
80
+ , PUNCT O
81
+ spike NOUN B-LF
82
+ number NOUN I-LF
83
+ per ADP I-LF
84
+ meter NOUN I-LF
85
+ ( PUNCT O
86
+ SN PROPN B-AC
87
+ ) PUNCT O
88
+ , PUNCT O
89
+ grain NOUN B-LF
90
+ number NOUN I-LF
91
+ per ADP I-LF
92
+ spike NOUN I-LF
93
+ ( PUNCT O
94
+ GN PROPN B-AC
95
+ ) PUNCT O
96
+ , PUNCT O
97
+ harvest NOUN B-LF
98
+ index NOUN I-LF
99
+ ( PUNCT O
100
+ HI PROPN B-AC
101
+ ) PUNCT O
102
+ , PUNCT O
103
+ N NOUN B-LF
104
+ harvest NOUN I-LF
105
+ index NOUN I-LF
106
+ ( PUNCT O
107
+ NHI PROPN B-AC
108
+ ) PUNCT O
109
+ , PUNCT O
110
+ GPC PROPN B-AC
111
+ , PUNCT O
112
+ NUE PROPN B-AC
113
+ , PUNCT O
114
+ NUpE PROPN B-AC
115
+ , PUNCT O
116
+ NUtE PROPN B-AC
117
+ , PUNCT O
118
+ amount NOUN O
119
+ of ADP O
120
+ N NOUN O
121
+ taken VERB O
122
+ up ADP O
123
+ by ADP O
124
+ the DET O
125
+ whole ADJ O
126
+ plant NOUN O
127
+ ( PUNCT O
128
+ NUpfull PROPN B-AC
129
+ ) PUNCT O
130
+ , PUNCT O
131
+ amount NOUN O
132
+ of ADP O
133
+ the DET O
134
+ N NOUN O
135
+ harvested VERB O
136
+ in ADP O
137
+ grain NOUN O
138
+ ( PUNCT O
139
+ NUpgrain PROPN B-AC
140
+ ) PUNCT O
141
+ , PUNCT O
142
+ grain NOUN B-LF
143
+ N NOUN I-LF
144
+ accumulation NOUN I-LF
145
+ efficiency NOUN I-LF
146
+ ( PUNCT O
147
+ GNACE PROPN B-AC
148
+ ) PUNCT O
149
+ . PUNCT O
150
+ GY PROPN B-AC
151
+ , PUNCT O
152
+ HD PROPN B-AC
153
+ and CCONJ O
154
+ PH PROPN B-AC
155
+ were AUX O
156
+ scored VERB O
157
+ on ADP O
158
+ a DET O
159
+ per ADP O
160
+ plot NOUN O
161
+ basis NOUN O
162
+ , PUNCT O
163
+ while SCONJ O
164
+ GN PROPN B-AC
165
+ , PUNCT O
166
+ SN PROPN B-AC
167
+ , PUNCT O
168
+ TGW PROPN B-AC
169
+ and CCONJ O
170
+ SY PROPN B-AC
171
+ were AUX O
172
+ evaluated VERB O
173
+ from ADP O
174
+ above ADP O
175
+ - PUNCT O
176
+ ground NOUN O
177
+ biomass NOUN O
178
+ samples NOUN O
179
+ collected VERB O
180
+ from ADP O
181
+ a DET O
182
+ representative ADJ O
183
+ row NOUN O
184
+ of ADP O
185
+ each DET O
186
+ plot NOUN O
187
+ , PUNCT O
188
+ whose DET O
189
+ length NOUN O
190
+ was AUX O
191
+ one NUM O
192
+ meter NOUN O
193
+ . PUNCT O
194
+
195
+ AVR PROPN B-AC
196
+ - PUNCT O
197
+ Aortic ADJ B-LF
198
+ valve NOUN I-LF
199
+ replacement NOUN I-LF
200
+ , PUNCT O
201
+ TAVI PROPN B-AC
202
+ – PUNCT O
203
+ transcutaneous ADJ O
204
+ aortic ADJ O
205
+ valve NOUN O
206
+ implantation NOUN O
207
+
208
+ After ADP O
209
+ amelogenin NOUN O
210
+ , PUNCT O
211
+ ameloblastin NOUN B-LF
212
+ ( PUNCT O
213
+ AMBN PROPN B-AC
214
+ ) PUNCT O
215
+ is AUX O
216
+ the DET O
217
+ second ADV O
218
+ most ADV O
219
+ abundant ADJ O
220
+ enamel NOUN O
221
+ matrix NOUN O
222
+ protein NOUN O
223
+ . PUNCT O
224
+
225
+ To PART O
226
+ address VERB O
227
+ the DET O
228
+ association NOUN O
229
+ between ADP O
230
+ a DET O
231
+ history NOUN O
232
+ of ADP O
233
+ tuberculosis NOUN B-LF
234
+ ( PUNCT O
235
+ TB PROPN B-AC
236
+ ) PUNCT O
237
+ or CCONJ O
238
+ nontuberculous ADJ O
239
+ mycobacterial ADJ O
240
+ ( PUNCT O
241
+ NTM PROPN B-AC
242
+ ) PUNCT O
243
+ infection NOUN O
244
+ and CCONJ O
245
+ the DET O
246
+ risk NOUN O
247
+ of ADP O
248
+ newly ADV O
249
+ diagnosed VERB O
250
+ Sjögren PROPN B-LF
251
+ ’s PART I-LF
252
+ syndrome NOUN I-LF
253
+ ( PUNCT O
254
+ SS PROPN B-AC
255
+ ) PUNCT O
256
+ . PUNCT O
257
+
258
+ As SCONJ O
259
+ SIRS PROPN B-AC
260
+ caused VERB O
261
+ by ADP O
262
+ tissue NOUN O
263
+ damage NOUN O
264
+ increases VERB O
265
+ the DET O
266
+ release NOUN O
267
+ of ADP O
268
+ damage NOUN B-LF
269
+ - PUNCT I-LF
270
+ associated VERB I-LF
271
+ molecular ADJ I-LF
272
+ patterns NOUN I-LF
273
+ ( PUNCT O
274
+ DAMPs PROPN B-AC
275
+ ) PUNCT O
276
+ , PUNCT O
277
+ SIRS PROPN B-AC
278
+ becomes VERB O
279
+ more ADV O
280
+ severe ADJ O
281
+ and CCONJ O
282
+ the DET O
283
+ multiple ADJ O
284
+ organ NOUN O
285
+ failure NOUN O
286
+ of ADP O
287
+ the DET O
288
+ patient NOUN O
289
+ worsens VERB O
290
+ . PUNCT O
291
+
292
+ EV PROPN B-AC
293
+ , PUNCT O
294
+ extracellular ADJ B-LF
295
+ vesicle NOUN I-LF
296
+ ; PUNCT O
297
+ NSC PROPN B-AC
298
+ , PUNCT O
299
+ neural ADJ B-LF
300
+ stem NOUN I-LF
301
+ cell NOUN I-LF
302
+ ; PUNCT O
303
+ WB PROPN B-AC
304
+ , PUNCT O
305
+ western ADJ B-LF
306
+ blot NOUN I-LF
307
+ . PUNCT O
308
+
309
+ The DET O
310
+ same ADJ O
311
+ experiment NOUN O
312
+ was AUX O
313
+ also ADV O
314
+ conducted VERB O
315
+ in ADP O
316
+ the DET O
317
+ 2011 NUM O
318
+ DS PROPN B-AC
319
+ , PUNCT O
320
+ 2011 NUM O
321
+ WS PROPN B-AC
322
+ and CCONJ O
323
+ 2012 NUM O
324
+ WS PROPN B-AC
325
+ but CCONJ O
326
+ only ADV O
327
+ phenology NOUN O
328
+ and CCONJ O
329
+ final ADJ O
330
+ crop NOUN O
331
+ aboveground ADJ B-LF
332
+ dry ADJ I-LF
333
+ weight NOUN I-LF
334
+ ( PUNCT O
335
+ agdw NOUN B-AC
336
+ ) PUNCT O
337
+ are AUX O
338
+ reported VERB O
339
+ here ADV O
340
+ . PUNCT O
341
+
342
+ Of ADP O
343
+ these PRON O
344
+ , PUNCT O
345
+ Nucleolar ADJ B-LF
346
+ and CCONJ I-LF
347
+ spindle NOUN I-LF
348
+ - PUNCT I-LF
349
+ associated VERB I-LF
350
+ protein NOUN I-LF
351
+ 1 NUM I-LF
352
+ ( PUNCT O
353
+ NUSAP1 PROPN B-AC
354
+ ) PUNCT O
355
+ was AUX O
356
+ detected VERB O
357
+ as ADP O
358
+ a DET O
359
+ significantly ADV O
360
+ upregulated VERB O
361
+ gene NOUN O
362
+ . PUNCT O
363
+
364
+ Mitochondrial ADJ O
365
+ fusion NOUN O
366
+ / SYM O
367
+ fission NOUN O
368
+ is AUX O
369
+ primarily ADV O
370
+ regulated VERB O
371
+ by ADP O
372
+ dynamin NOUN O
373
+ - PUNCT O
374
+ like ADJ O
375
+ GTPase PROPN O
376
+ , PUNCT O
377
+ optic ADJ B-LF
378
+ atrophy NOUN I-LF
379
+ 1 NUM I-LF
380
+ ( PUNCT O
381
+ Opa1 PROPN B-AC
382
+ ) PUNCT O
383
+ and CCONJ O
384
+ dynamin NOUN B-LF
385
+ - PUNCT I-LF
386
+ related VERB I-LF
387
+ protein NOUN I-LF
388
+ 1 NUM I-LF
389
+ ( PUNCT O
390
+ Drp1 PROPN B-AC
391
+ , PUNCT O
392
+ mitofusin NOUN O
393
+ 1/2 NUM O
394
+ ( PUNCT O
395
+ Mfn1/2 NOUN O
396
+ ) PUNCT O
397
+ [ PUNCT O
398
+ 40–42 NUM O
399
+ ] PUNCT O
400
+ . PUNCT O
401
+
402
+ We PRON O
403
+ carried VERB O
404
+ out ADP O
405
+ a DET O
406
+ series NOUN O
407
+ of ADP O
408
+ experimental ADJ O
409
+ studies NOUN O
410
+ in ADP O
411
+ order NOUN O
412
+ to PART O
413
+ obtain VERB O
414
+ behavioural ADJ O
415
+ data NOUN O
416
+ from ADP O
417
+ rats NOUN O
418
+ given VERB O
419
+ low ADJ O
420
+ , PUNCT O
421
+ medium ADJ O
422
+ , PUNCT O
423
+ and CCONJ O
424
+ high ADJ O
425
+ doses NOUN O
426
+ of ADP O
427
+ peptide NOUN B-LF
428
+ YY3 PROPN I-LF
429
+ - PUNCT I-LF
430
+ 36 NUM I-LF
431
+ ( PUNCT O
432
+ PYY3 PROPN B-AC
433
+ - PUNCT B-AC
434
+ 36 NUM B-AC
435
+ ) PUNCT O
436
+ in ADP O
437
+ the DET O
438
+ light ADJ O
439
+ and CCONJ O
440
+ dark ADJ O
441
+ period NOUN O
442
+ , PUNCT O
443
+ as ADP O
444
+ well ADV O
445
+ as ADP O
446
+ rats NOUN O
447
+ given VERB O
448
+ low ADJ O
449
+ and CCONJ O
450
+ high ADJ O
451
+ doses NOUN O
452
+ of ADP O
453
+ lithium NOUN O
454
+ chloride NOUN O
455
+ ( PUNCT O
456
+ LiCl PROPN O
457
+ ) PUNCT O
458
+ in ADP O
459
+ the DET O
460
+ light ADJ O
461
+ period NOUN O
462
+ and CCONJ O
463
+ rats NOUN O
464
+ given VERB O
465
+ low ADJ O
466
+ , PUNCT O
467
+ medium ADJ O
468
+ , PUNCT O
469
+ and CCONJ O
470
+ high ADJ O
471
+ doses NOUN O
472
+ of ADP O
473
+ glucagon NOUN B-LF
474
+ - PUNCT I-LF
475
+ like ADJ I-LF
476
+ peptide NOUN I-LF
477
+ 1 NUM I-LF
478
+ ( PUNCT O
479
+ GLP-1 PROPN B-AC
480
+ ) PUNCT O
481
+ and CCONJ O
482
+ leptin NOUN O
483
+ in ADP O
484
+ the DET O
485
+ dark ADJ O
486
+ period NOUN O
487
+ ( PUNCT O
488
+ details NOUN O
489
+ and CCONJ O
490
+ doses NOUN O
491
+ in ADP O
492
+ Table PROPN O
493
+ 2 NUM O
494
+ and CCONJ O
495
+ Materials NOUN O
496
+ and CCONJ O
497
+ Methods NOUN O
498
+ ) PUNCT O
499
+ . PUNCT O
500
+
501
+ Olfactory ADJ B-LF
502
+ sensory ADJ I-LF
503
+ neurons NOUN I-LF
504
+ ( PUNCT O
505
+ OSNs PROPN B-AC
506
+ ) PUNCT O
507
+ in ADP O
508
+ most ADJ O
509
+ vertebrates NOUN O
510
+ and CCONJ O
511
+ insects NOUN O
512
+ are AUX O
513
+ specified VERB O
514
+ to PART O
515
+ express VERB O
516
+ a DET O
517
+ single ADJ O
518
+ odorant NOUN B-LF
519
+ receptor NOUN I-LF
520
+ ( PUNCT O
521
+ OR PROPN B-AC
522
+ ) PUNCT O
523
+ from ADP O
524
+ a DET O
525
+ large ADJ O
526
+ repertoire NOUN O
527
+ of ADP O
528
+ OR PROPN B-AC
529
+ genes NOUN O
530
+ in ADP O
531
+ the DET O
532
+ genome NOUN O
533
+ [ X O
534
+ 1–4 NUM O
535
+ ] PUNCT O
536
+ . PUNCT O
537
+
538
+ Combined ADJ B-LF
539
+ hepatocellular ADJ I-LF
540
+ - PUNCT I-LF
541
+ cholangiocarcinoma NOUN I-LF
542
+ ( PUNCT O
543
+ cHCC NOUN B-AC
544
+ - PUNCT B-AC
545
+ CC NOUN B-AC
546
+ ) PUNCT O
547
+ accounts VERB O
548
+ for ADP O
549
+ 0.4%–14.2 NUM O
550
+ % NOUN O
551
+ of ADP O
552
+ primary ADJ O
553
+ liver NOUN O
554
+ malignancies NOUN O
555
+ [ PUNCT O
556
+ 1 NUM O
557
+ , PUNCT O
558
+ 2 NUM O
559
+ ] PUNCT O
560
+ , PUNCT O
561
+ and CCONJ O
562
+ contains VERB O
563
+ pathological ADJ O
564
+ components NOUN O
565
+ of ADP O
566
+ both CCONJ O
567
+ hepatocellular ADJ B-LF
568
+ carcinoma NOUN I-LF
569
+ ( PUNCT O
570
+ HCC PROPN B-AC
571
+ ) PUNCT O
572
+ and CCONJ O
573
+ cholangiocarcinoma NOUN B-LF
574
+ ( PUNCT O
575
+ CC NOUN B-AC
576
+ ) PUNCT O
577
+ [ PUNCT O
578
+ 3 NUM O
579
+ ] PUNCT O
580
+ . PUNCT O
581
+
582
+ “ PUNCT O
583
+ Post PROPN O
584
+ - ADJ O
585
+ Tax ADJ O
586
+ : PUNCT O
587
+ Behavior NOUN O
588
+ Only ADV O
589
+ ” PUNCT O
590
+ refers VERB O
591
+ to ADP O
592
+ estimates NOUN O
593
+ of ADP O
594
+ beverage NOUN O
595
+ intake NOUN O
596
+ using VERB O
597
+ only ADV O
598
+ the DET O
599
+ pre ADJ O
600
+ - ADJ O
601
+ tax ADJ O
602
+ food NOUN B-LF
603
+ composition NOUN I-LF
604
+ table NOUN I-LF
605
+ ( PUNCT O
606
+ FCT PROPN B-AC
607
+ ) PUNCT O
608
+ , PUNCT O
609
+ which PRON O
610
+ keeps VERB O
611
+ nutrient NOUN O
612
+ content NOUN O
613
+ constant ADJ O
614
+ . PUNCT O
615
+ “ PUNCT O
616
+ Post PROPN O
617
+ - ADJ O
618
+ Tax ADJ O
619
+ : PUNCT O
620
+ Reformulation NOUN O
621
+ Included VERB O
622
+ ” PUNCT O
623
+ refers VERB O
624
+ to ADP O
625
+ estimates NOUN O
626
+ of ADP O
627
+ beverage NOUN O
628
+ intake NOUN O
629
+ using VERB O
630
+ the DET O
631
+ post ADJ O
632
+ - ADJ O
633
+ tax ADJ O
634
+ FCT PROPN B-AC
635
+ , PUNCT O
636
+ which PRON O
637
+ accounts VERB O
638
+ for ADP O
639
+ reformulation NOUN O
640
+ changes NOUN O
641
+ in ADP O
642
+ the DET O
643
+ nutrient NOUN O
644
+ content NOUN O
645
+ of ADP O
646
+ beverages NOUN O
647
+ . PUNCT O
648
+
649
+ b X O
650
+ GH NOUN B-AC
651
+ : PUNCT O
652
+ growth NOUN B-LF
653
+ hormone NOUN I-LF
654
+
655
+ IES PROPN B-AC
656
+ , PUNCT O
657
+ internal ADJ B-LF
658
+ eliminated VERB I-LF
659
+ sequence NOUN I-LF
660
+ . PUNCT O
661
+
662
+ Compared VERB O
663
+ to ADP O
664
+ the DET O
665
+ X NOUN O
666
+ - PUNCT O
667
+ ray NOUN O
668
+ crystal NOUN O
669
+ structure NOUN O
670
+ of ADP O
671
+ the DET O
672
+ template NOUN O
673
+ ( PUNCT O
674
+ PDB NOUN O
675
+ code NOUN O
676
+ 4F13 NUM O
677
+ ) PUNCT O
678
+ [ PUNCT O
679
+ 32 NUM O
680
+ ] PUNCT O
681
+ , PUNCT O
682
+ the DET O
683
+ geometrical ADJ O
684
+ root NOUN B-LF
685
+ - PUNCT I-LF
686
+ mean NOUN I-LF
687
+ square ADJ I-LF
688
+ deviation NOUN I-LF
689
+ ( PUNCT O
690
+ RMSD NOUN B-AC
691
+ ) PUNCT O
692
+ for ADP O
693
+ the DET O
694
+ Cα PROPN O
695
+ atoms NOUN O
696
+ of ADP O
697
+ the DET O
698
+ modeled VERB O
699
+ AlgL PROPN B-AC
700
+ structure NOUN O
701
+ was AUX O
702
+ very ADV O
703
+ low ADJ O
704
+ ( PUNCT O
705
+ 1.03 NUM O
706
+ Å NOUN O
707
+ ) PUNCT O
708
+ , PUNCT O
709
+ suggesting VERB O
710
+ the DET O
711
+ high ADJ O
712
+ fidelity NOUN O
713
+ of ADP O
714
+ the DET O
715
+ modeled VERB O
716
+ structure NOUN O
717
+ . PUNCT O
718
+
719
+ CI PROPN B-AC
720
+ , PUNCT O
721
+ confidence NOUN B-LF
722
+ interval NOUN I-LF
723
+ ; PUNCT O
724
+ non ADJ O
725
+ - ADJ O
726
+ UHCS ADJ B-AC
727
+ , PUNCT O
728
+ non ADJ O
729
+ - ADJ O
730
+ universal ADJ B-LF
731
+ health NOUN I-LF
732
+ care NOUN I-LF
733
+ system NOUN I-LF
734
+ ; PUNCT O
735
+ NR PROPN O
736
+ , PUNCT O
737
+ not PART O
738
+ reported VERB O
739
+ ; PUNCT O
740
+ OR PROPN B-AC
741
+ , PUNCT O
742
+ odds NOUN B-LF
743
+ ratio NOUN I-LF
744
+ ; PUNCT O
745
+ SEER PROPN B-AC
746
+ , PUNCT O
747
+ National PROPN B-LF
748
+ Cancer PROPN I-LF
749
+ Institute PROPN I-LF
750
+ 's PART I-LF
751
+ Surveillance PROPN I-LF
752
+ , PUNCT I-LF
753
+ Epidemiology PROPN I-LF
754
+ and CCONJ I-LF
755
+ End PROPN I-LF
756
+ Results PROPN I-LF
757
+ database NOUN O
758
+ ; PUNCT O
759
+ SEP PROPN B-AC
760
+ , PUNCT O
761
+ socioeconomic ADJ B-LF
762
+ position NOUN I-LF
763
+ . PUNCT O
764
+
765
+ Past ADJ O
766
+ studies NOUN O
767
+ have AUX O
768
+ found VERB O
769
+ an DET O
770
+ association NOUN O
771
+ between ADP O
772
+ low ADJ O
773
+ levels NOUN O
774
+ of ADP O
775
+ hemoglobin NOUN B-LF
776
+ A1c NOUN I-LF
777
+ ( PUNCT O
778
+ HbA1c NOUN B-AC
779
+ , PUNCT O
780
+ a DET O
781
+ marker NOUN O
782
+ of ADP O
783
+ average ADJ O
784
+ blood NOUN O
785
+ sugar NOUN O
786
+ levels NOUN O
787
+ over ADP O
788
+ the DET O
789
+ past ADJ O
790
+ 2–3 NUM O
791
+ months NOUN O
792
+ ; PUNCT O
793
+ a DET O
794
+ low ADJ O
795
+ HbA1c NOUN B-AC
796
+ percentage NOUN O
797
+ indicates VERB O
798
+ good ADJ O
799
+ glycemic ADJ O
800
+ control NOUN O
801
+ ) PUNCT O
802
+ and CCONJ O
803
+ a DET O
804
+ high ADJ O
805
+ risk NOUN O
806
+ of ADP O
807
+ severe ADJ O
808
+ hypoglycemia NOUN O
809
+ . PUNCT O
810
+
811
+ Abbreviations NOUN O
812
+ : NOUN O
813
+ mPAP PROPN B-AC
814
+ = VERB O
815
+ mean ADJ B-LF
816
+ pulmonary ADJ I-LF
817
+ artery NOUN I-LF
818
+ pressure NOUN I-LF
819
+ ; PUNCT O
820
+ PA PROPN B-AC
821
+ : NOUN B-AC
822
+ A NOUN B-AC
823
+ = VERB O
824
+ pulmonary ADJ B-LF
825
+ artery NOUN I-LF
826
+ to ADP O
827
+ ascending ADJ O
828
+ aorta NOUN O
829
+ diameter NOUN O
830
+ ratio NOUN O
831
+ ; PUNCT O
832
+ PH NOUN B-AC
833
+ = VERB O
834
+ pulmonary ADJ B-LF
835
+ hypertension NOUN I-LF
836
+ . PUNCT O
837
+
838
+ PUD PROPN B-AC
839
+ ; PUNCT O
840
+ Peptic ADJ B-LF
841
+ Ulcer NOUN I-LF
842
+ Disease NOUN I-LF
843
+
844
+ Specifically ADV O
845
+ , PUNCT O
846
+ administration NOUN O
847
+ of ADP O
848
+ the DET O
849
+ TB PROPN B-AC
850
+ vaccine NOUN O
851
+ bacillus NOUN B-LF
852
+ Calmette PROPN I-LF
853
+ – PUNCT I-LF
854
+ Guérin PROPN I-LF
855
+ ( PUNCT O
856
+ BCG PROPN B-AC
857
+ ) PUNCT O
858
+ or CCONJ O
859
+ measles NOUN O
860
+ vaccines NOUN O
861
+ in ADP O
862
+ children NOUN O
863
+ reduces VERB O
864
+ overall ADJ O
865
+ mortality NOUN O
866
+ by ADP O
867
+ more ADJ O
868
+ than ADP O
869
+ what PRON O
870
+ would AUX O
871
+ be AUX O
872
+ expected VERB O
873
+ by ADP O
874
+ prevention NOUN O
875
+ of ADP O
876
+ these DET O
877
+ 2 NUM O
878
+ diseases NOUN O
879
+ alone ADV O
880
+ [ PUNCT O
881
+ 12 NUM O
882
+ ] PUNCT O
883
+ . PUNCT O
884
+
885
+ To PART O
886
+ test VERB O
887
+ this DET O
888
+ hypothesis NOUN O
889
+ , PUNCT O
890
+ we PRON O
891
+ predicted VERB O
892
+ errors NOUN O
893
+ in ADP O
894
+ the DET O
895
+ reported VERB O
896
+ diameter NOUN O
897
+ size NOUN O
898
+ of ADP O
899
+ the DET O
900
+ retro ADJ O
901
+ - ADJ O
902
+ cued VERB O
903
+ circle NOUN O
904
+ as ADP O
905
+ a DET O
906
+ function NOUN O
907
+ of ADP O
908
+ the DET O
909
+ competitor(s NOUN B-LF
910
+ ) PUNCT I-LF
911
+ relative ADJ I-LF
912
+ size NOUN I-LF
913
+ ( PUNCT O
914
+ ΔC NOUN B-AC
915
+ ) PUNCT O
916
+ and CCONJ O
917
+ of ADP O
918
+ the DET O
919
+ ΔS NOUN B-AC
920
+ — PUNCT O
921
+ i.e. X O
922
+ , PUNCT O
923
+ the DET O
924
+ difference NOUN O
925
+ between ADP O
926
+ the DET O
927
+ previous ADJ O
928
+ and CCONJ O
929
+ the DET O
930
+ current ADJ O
931
+ target NOUN O
932
+ circle NOUN O
933
+ ’s PART O
934
+ size NOUN O
935
+ . PUNCT O
936
+
937
+ The DET O
938
+ second ADJ O
939
+ group NOUN O
940
+ “ PUNCT O
941
+ Complete PROPN B-LF
942
+ Granulation PROPN I-LF
943
+ Bed PROPN I-LF
944
+ ” PUNCT O
945
+ ( PUNCT O
946
+ CGB PROPN B-AC
947
+ ) PUNCT O
948
+ included VERB O
949
+ wounds NOUN O
950
+ with ADP O
951
+ a DET O
952
+ complete ADJ B-LF
953
+ granulation NOUN I-LF
954
+ bed NOUN I-LF
955
+ , PUNCT O
956
+ or CCONJ O
957
+ only ADV O
958
+ minor ADJ O
959
+ clefts NOUN O
960
+ or CCONJ O
961
+ defects NOUN O
962
+ of ADP O
963
+ less ADJ O
964
+ than ADP O
965
+ 0.5 NUM O
966
+ cm NOUN O
967
+ depth NOUN O
968
+ . PUNCT O
969
+
970
+ IFOF PROPN B-AC
971
+ , PUNCT O
972
+ inferior ADJ B-LF
973
+ fronto ADJ I-LF
974
+ - PUNCT I-LF
975
+ occipital ADJ I-LF
976
+ fascicle NOUN I-LF
977
+ ; PUNCT O
978
+ ILF PROPN B-AC
979
+ , PUNCT O
980
+ inferior ADJ B-LF
981
+ longitudinal ADJ I-LF
982
+ fascicle NOUN I-LF
983
+ ; PUNCT O
984
+ ILFlat PROPN B-AC
985
+ , PUNCT O
986
+ inferior ADJ B-LF
987
+ longitudinal ADJ I-LF
988
+ fascicle NOUN I-LF
989
+ lateral ADJ O
990
+ ; PUNCT O
991
+ ILFmed PROPN B-AC
992
+ , PUNCT O
993
+ inferior ADJ B-LF
994
+ longitudinal ADJ I-LF
995
+ fascicle NOUN I-LF
996
+ medial ADJ O
997
+ ; PUNCT O
998
+ KL PROPN B-AC
999
+ , PUNCT O
1000
+ Kullback PROPN B-LF
1001
+ – PUNCT I-LF
1002
+ Liebler PROPN I-LF
1003
+ ; PUNCT O
1004
+ MdLF PROPN B-AC
1005
+ , PUNCT O
1006
+ middle ADJ B-LF
1007
+ longitudinal ADJ I-LF
1008
+ fascicle NOUN I-LF
1009
+ ; PUNCT O
1010
+ PRIME PROPN O
1011
+ - PUNCT O
1012
+ DE PROPN O
1013
+ , PUNCT O
1014
+ Primate PROPN O
1015
+ Data PROPN O
1016
+ Exchange PROPN O
1017
+ . PUNCT O
1018
+
1019
+ Abbreviations NOUN O
1020
+ : PUNCT O
1021
+ BP PROPN B-AC
1022
+ , PUNCT O
1023
+ blood NOUN B-LF
1024
+ pressure NOUN I-LF
1025
+ ; PUNCT O
1026
+ sBP NOUN B-AC
1027
+ , PUNCT O
1028
+ systolic ADJ B-LF
1029
+ blood NOUN I-LF
1030
+ pressure NOUN I-LF
1031
+ . PUNCT O
1032
+
1033
+ Integrated VERB O
1034
+ muscle NOUN O
1035
+ protein NOUN O
1036
+ balance NOUN O
1037
+ has AUX O
1038
+ been AUX O
1039
+ calculated VERB O
1040
+ for ADP O
1041
+ the DET O
1042
+ following VERB O
1043
+ periods NOUN O
1044
+ of ADP O
1045
+ time NOUN O
1046
+ : PUNCT O
1047
+ post ADJ B-LF
1048
+ absorptive ADJ I-LF
1049
+ period NOUN O
1050
+ ( PUNCT O
1051
+ PA NOUN B-AC
1052
+ ) PUNCT O
1053
+ ( PUNCT O
1054
+ 0–150min NUM O
1055
+ ) PUNCT O
1056
+ , PUNCT O
1057
+ early ADJ O
1058
+ post ADJ B-LF
1059
+ prandial ADJ I-LF
1060
+ period NOUN O
1061
+ ( PUNCT O
1062
+ PP NOUN B-AC
1063
+ ) PUNCT O
1064
+ ( PUNCT O
1065
+ 150–300min NUM O
1066
+ ) PUNCT O
1067
+ and CCONJ O
1068
+ late ADJ O
1069
+ post ADJ B-LF
1070
+ prandial ADJ I-LF
1071
+ period NOUN O
1072
+ ( PUNCT O
1073
+ PP NOUN B-AC
1074
+ ) PUNCT O
1075
+ ( PUNCT O
1076
+ 300–550min NUM O
1077
+ ) PUNCT O
1078
+ . PUNCT O
1079
+
1080
+ Multiple ADJ O
1081
+ sources NOUN O
1082
+ were AUX O
1083
+ used VERB O
1084
+ , PUNCT O
1085
+ integrating VERB O
1086
+ the DET O
1087
+ hospital NOUN B-LF
1088
+ discharge NOUN I-LF
1089
+ register NOUN I-LF
1090
+ ( PUNCT O
1091
+ HDR PROPN B-AC
1092
+ ) PUNCT O
1093
+ , PUNCT O
1094
+ clinical ADJ O
1095
+ charts NOUN O
1096
+ , PUNCT O
1097
+ spirometry NOUN O
1098
+ and CCONJ O
1099
+ the DET O
1100
+ cause NOUN B-LF
1101
+ - PUNCT I-LF
1102
+ specific ADJ I-LF
1103
+ mortality NOUN I-LF
1104
+ register NOUN I-LF
1105
+ ( PUNCT O
1106
+ CMR PROPN B-AC
1107
+ ) PUNCT O
1108
+ in ADP O
1109
+ a DET O
1110
+ longitudinal ADJ O
1111
+ algorithm NOUN O
1112
+ , PUNCT O
1113
+ to PART O
1114
+ reduce VERB O
1115
+ underestimation NOUN O
1116
+ of ADP O
1117
+ COPD PROPN B-AC
1118
+ prevalence NOUN O
1119
+ . PUNCT O
1120
+
1121
+ Unadjusted ADJ O
1122
+ prevalence NOUN B-LF
1123
+ risk NOUN I-LF
1124
+ ratios NOUN I-LF
1125
+ ( PUNCT O
1126
+ PRRs NOUN B-AC
1127
+ ) PUNCT O
1128
+ and CCONJ O
1129
+ adjusted VERB O
1130
+ PRRs NOUN B-AC
1131
+ ( PUNCT O
1132
+ adjPRRs NOUN B-AC
1133
+ ) PUNCT O
1134
+ of ADP O
1135
+ HIV PROPN O
1136
+ shedding NOUN O
1137
+ were AUX O
1138
+ estimated VERB O
1139
+ using VERB O
1140
+ modified VERB O
1141
+ Poisson PROPN O
1142
+ regression NOUN O
1143
+ with ADP O
1144
+ robust ADJ O
1145
+ variance NOUN O
1146
+ . PUNCT O
1147
+
1148
+ The DET O
1149
+ myocardial ADJ O
1150
+ extracellular ADJ B-LF
1151
+ matrix NOUN I-LF
1152
+ ( PUNCT O
1153
+ ECM PROPN B-AC
1154
+ ) PUNCT O
1155
+ is AUX O
1156
+ a DET O
1157
+ critical ADJ O
1158
+ component NOUN O
1159
+ in ADP O
1160
+ normal ADJ O
1161
+ and CCONJ O
1162
+ pathophysiological ADJ O
1163
+ conditions NOUN O
1164
+ of ADP O
1165
+ the DET O
1166
+ heart NOUN O
1167
+ , PUNCT O
1168
+ and CCONJ O
1169
+ is AUX O
1170
+ mainly ADV O
1171
+ regulated VERB O
1172
+ by ADP O
1173
+ cardiac ADJ O
1174
+ fibroblasts NOUN O
1175
+ [ PUNCT O
1176
+ 1 NUM O
1177
+ ] PUNCT O
1178
+ . PUNCT O
1179
+
1180
+ Furthermore ADV O
1181
+ , PUNCT O
1182
+ the DET O
1183
+ complete ADJ O
1184
+ lack NOUN O
1185
+ of ADP O
1186
+ access NOUN O
1187
+ to ADP O
1188
+ health NOUN O
1189
+ care NOUN O
1190
+ , PUNCT O
1191
+ absence NOUN O
1192
+ of ADP O
1193
+ skilled ADJ O
1194
+ delivery NOUN O
1195
+ services NOUN O
1196
+ , PUNCT O
1197
+ or CCONJ O
1198
+ delayed VERB O
1199
+ entry NOUN O
1200
+ into ADP O
1201
+ antenatal ADJ B-LF
1202
+ care NOUN I-LF
1203
+ ( PUNCT O
1204
+ ANC PROPN B-AC
1205
+ ) PUNCT O
1206
+ deprive VERB O
1207
+ both CCONJ O
1208
+ the DET O
1209
+ teenage ADJ O
1210
+ mother NOUN O
1211
+ and CCONJ O
1212
+ her PRON O
1213
+ offspring NOUN O
1214
+ of ADP O
1215
+ basic ADJ O
1216
+ health NOUN O
1217
+ care NOUN O
1218
+ services NOUN O
1219
+ [ PUNCT O
1220
+ 4 NUM O
1221
+ ] PUNCT O
1222
+ . PUNCT O
1223
+
1224
+ This DET O
1225
+ antiviral ADJ O
1226
+ response NOUN O
1227
+ is AUX O
1228
+ triggered VERB O
1229
+ by ADP O
1230
+ virus NOUN O
1231
+ - PUNCT O
1232
+ specific ADJ O
1233
+ double ADJ B-LF
1234
+ - PUNCT I-LF
1235
+ stranded ADJ I-LF
1236
+ RNA NOUN I-LF
1237
+ molecules NOUN O
1238
+ ( PUNCT O
1239
+ dsRNAs NOUN B-AC
1240
+ ) PUNCT O
1241
+ that PRON O
1242
+ are AUX O
1243
+ produced VERB O
1244
+ during ADP O
1245
+ infection NOUN O
1246
+ . PUNCT O
1247
+
1248
+ The DET O
1249
+ receiver NOUN B-LF
1250
+ operating NOUN I-LF
1251
+ characteristic NOUN I-LF
1252
+ ( PUNCT O
1253
+ ROC PROPN B-AC
1254
+ ) PUNCT O
1255
+ curves NOUN O
1256
+ show VERB O
1257
+ the DET O
1258
+ discrimination NOUN O
1259
+ of ADP O
1260
+ the DET O
1261
+ model NOUN O
1262
+ after ADP O
1263
+ including VERB O
1264
+ empirically ADV O
1265
+ diagnosed VERB O
1266
+ TB PROPN B-AC
1267
+ patients NOUN O
1268
+ in ADP O
1269
+ the DET O
1270
+ study NOUN O
1271
+ population NOUN O
1272
+ . PUNCT O
1273
+
1274
+ Furthermore ADV O
1275
+ , PUNCT O
1276
+ in ADP O
1277
+ patients NOUN O
1278
+ with ADP O
1279
+ HCV PROPN B-AC
1280
+ - ADJ O
1281
+ related VERB O
1282
+ cirrhosis NOUN O
1283
+ , PUNCT O
1284
+ the DET O
1285
+ primary ADJ O
1286
+ necro ADJ O
1287
+ - ADJ O
1288
+ inflammatory ADJ O
1289
+ stimulus NOUN O
1290
+ ( PUNCT O
1291
+ i.e. X O
1292
+ the DET O
1293
+ hepatitis PROPN B-LF
1294
+ C PROPN I-LF
1295
+ virus NOUN I-LF
1296
+ ) PUNCT O
1297
+ is AUX O
1298
+ still ADV O
1299
+ present ADJ O
1300
+ , PUNCT O
1301
+ whereas SCONJ O
1302
+ in ADP O
1303
+ ALD PROPN B-AC
1304
+ or CCONJ O
1305
+ NAFLD PROPN B-AC
1306
+ - ADJ O
1307
+ related VERB O
1308
+ cirrhosis NOUN O
1309
+ , PUNCT O
1310
+ the DET O
1311
+ primary ADJ O
1312
+ necro ADJ O
1313
+ - ADJ O
1314
+ inflammatory ADJ O
1315
+ stimulus NOUN O
1316
+ ( PUNCT O
1317
+ i.e. X O
1318
+ alcohol NOUN O
1319
+ use NOUN O
1320
+ in ADP O
1321
+ ALD PROPN B-AC
1322
+ or CCONJ O
1323
+ a DET O
1324
+ hypothesized VERB O
1325
+ lipotoxic ADJ O
1326
+ molecule NOUN O
1327
+ in ADP O
1328
+ NAFLD PROPN B-AC
1329
+ ) PUNCT O
1330
+ may AUX O
1331
+ or CCONJ O
1332
+ may AUX O
1333
+ not PART O
1334
+ still ADV O
1335
+ be AUX O
1336
+ present ADJ O
1337
+ after ADP O
1338
+ the DET O
1339
+ development NOUN O
1340
+ of ADP O
1341
+ cirrhosis NOUN O
1342
+ . PUNCT O
1343
+
1344
+ PF PROPN B-AC
1345
+ : PUNCT O
1346
+ Processed VERB B-LF
1347
+ foods NOUN I-LF
1348
+ , PUNCT O
1349
+ EAR PROPN B-AC
1350
+ : PUNCT O
1351
+ Estimated VERB B-LF
1352
+ average ADJ I-LF
1353
+ requirement NOUN I-LF
1354
+ , PUNCT O
1355
+ RNI PROPN B-AC
1356
+ : PUNCT O
1357
+ Recommended VERB B-LF
1358
+ nutrient NOUN I-LF
1359
+ intake NOUN I-LF
1360
+ , PUNCT O
1361
+ UL PROPN B-AC
1362
+ : PUNCT O
1363
+ Tolerable ADJ B-LF
1364
+ upper ADJ I-LF
1365
+ intake NOUN I-LF
1366
+ limit NOUN I-LF
1367
+ ; PUNCT O
1368
+ for ADP O
1369
+ iodine NOUN O
1370
+ . PUNCT O
1371
+
1372
+ To PART O
1373
+ measure VERB O
1374
+ the DET O
1375
+ social ADJ O
1376
+ deprivation NOUN O
1377
+ of ADP O
1378
+ the DET O
1379
+ area NOUN O
1380
+ of ADP O
1381
+ residence NOUN O
1382
+ we PRON O
1383
+ used VERB O
1384
+ the DET O
1385
+ Welsh PROPN B-LF
1386
+ Index PROPN I-LF
1387
+ of ADP I-LF
1388
+ Multiple PROPN I-LF
1389
+ Deprivation PROPN I-LF
1390
+ ( PUNCT O
1391
+ WIMD PROPN B-AC
1392
+ ) PUNCT O
1393
+ 2005 NUM O
1394
+ at ADP O
1395
+ lower ADJ B-LF
1396
+ super ADJ I-LF
1397
+ output NOUN I-LF
1398
+ area NOUN I-LF
1399
+ ( PUNCT O
1400
+ LSOA PROPN B-AC
1401
+ ) PUNCT O
1402
+ level NOUN O
1403
+ , PUNCT O
1404
+ equivalent ADJ O
1405
+ to ADP O
1406
+ a DET O
1407
+ postcode NOUN O
1408
+ area NOUN O
1409
+ with ADP O
1410
+ a DET O
1411
+ minimum NOUN O
1412
+ of ADP O
1413
+ 1000 NUM O
1414
+ houses NOUN O
1415
+ and CCONJ O
1416
+ mean ADJ O
1417
+ 1500 NUM O
1418
+ houses NOUN O
1419
+ [ PUNCT O
1420
+ 29 NUM O
1421
+ ] PUNCT O
1422
+ . PUNCT O
1423
+
1424
+ Arp2/3 NOUN B-AC
1425
+ , PUNCT O
1426
+ actin NOUN B-LF
1427
+ - PUNCT I-LF
1428
+ related VERB I-LF
1429
+ protein NOUN I-LF
1430
+ 2/3 NUM I-LF
1431
+ ; PUNCT O
1432
+ CK-666 NOUN B-AC
1433
+ , PUNCT O
1434
+ Arp2/3 NOUN B-LF
1435
+ complex NOUN I-LF
1436
+ inhibitor NOUN I-LF
1437
+ I NUM I-LF
1438
+ ; PUNCT O
1439
+ WASp PROPN B-AC
1440
+ , PUNCT O
1441
+ Wiskott PROPN B-LF
1442
+ – PUNCT I-LF
1443
+ Aldrich PROPN I-LF
1444
+ syndrome PROPN I-LF
1445
+ protein NOUN I-LF
1446
+ . PUNCT O
1447
+
1448
+ GA PROPN B-AC
1449
+ = PUNCT O
1450
+ general ADJ B-LF
1451
+ anaesthesia NOUN I-LF
1452
+ ; PUNCT O
1453
+ MACCE PROPN B-AC
1454
+ = PUNCT O
1455
+ major ADJ O
1456
+ cardiac ADJ O
1457
+ and CCONJ O
1458
+ cerebrovascular ADJ O
1459
+ events NOUN O
1460
+
1461
+ In ADP O
1462
+ response NOUN O
1463
+ to PART O
1464
+ these DET O
1465
+ concerns NOUN O
1466
+ , PUNCT O
1467
+ in ADP O
1468
+ 2011 NUM O
1469
+ , PUNCT O
1470
+ an DET O
1471
+ Indian ADJ O
1472
+ parliamentary ADJ O
1473
+ standing NOUN O
1474
+ committee NOUN O
1475
+ closely ADV O
1476
+ examined VERB O
1477
+ the DET O
1478
+ Indian ADJ O
1479
+ national ADJ O
1480
+ drug NOUN O
1481
+ regulator NOUN O
1482
+ — PUNCT O
1483
+ the DET O
1484
+ Central PROPN O
1485
+ Drugs PROPN O
1486
+ Standard PROPN O
1487
+ Control PROPN O
1488
+ Organization PROPN O
1489
+ ( PUNCT O
1490
+ CDSCO PROPN B-AC
1491
+ ) PUNCT O
1492
+ . PUNCT O
1493
+ The DET O
1494
+ committee NOUN O
1495
+ ’s PART O
1496
+ report NOUN O
1497
+ , PUNCT O
1498
+ released VERB O
1499
+ in ADP O
1500
+ 2012 NUM O
1501
+ , PUNCT O
1502
+ highlighted VERB O
1503
+ multiple ADJ O
1504
+ deficiencies NOUN O
1505
+ in ADP O
1506
+ the DET O
1507
+ approval NOUN O
1508
+ processes NOUN O
1509
+ of ADP O
1510
+ the DET O
1511
+ CDSCO PROPN B-AC
1512
+ , PUNCT O
1513
+ including VERB O
1514
+ a DET O
1515
+ failure NOUN O
1516
+ to PART O
1517
+ test VERB O
1518
+ the DET O
1519
+ efficacy NOUN O
1520
+ and CCONJ O
1521
+ safety NOUN O
1522
+ of ADP O
1523
+ many ADJ O
1524
+ of ADP O
1525
+ the DET O
1526
+ FDCs NOUN B-AC
1527
+ available ADJ O
1528
+ in ADP O
1529
+ India PROPN O
1530
+ , PUNCT O
1531
+ but CCONJ O
1532
+ provided VERB O
1533
+ no DET O
1534
+ systematic ADJ O
1535
+ evidence NOUN O
1536
+ to PART O
1537
+ support VERB O
1538
+ its PRON O
1539
+ concerns NOUN O
1540
+ about ADP O
1541
+ FDCs NOUN B-AC
1542
+ . PUNCT O
1543
+ Here ADV O
1544
+ , PUNCT O
1545
+ the DET O
1546
+ researchers NOUN O
1547
+ undertake VERB O
1548
+ a DET O
1549
+ time NOUN O
1550
+ - ADJ O
1551
+ trend NOUN O
1552
+ analysis NOUN O
1553
+ of ADP O
1554
+ the DET O
1555
+ sales NOUN O
1556
+ volumes NOUN O
1557
+ of ADP O
1558
+ oral ADJ O
1559
+ FDCs NOUN B-AC
1560
+ for ADP O
1561
+ pain NOUN O
1562
+ relief NOUN O
1563
+ ( PUNCT O
1564
+ analgesia NOUN O
1565
+ ; PUNCT O
1566
+ formulations NOUN O
1567
+ of ADP O
1568
+ non ADJ B-LF
1569
+ - ADJ I-LF
1570
+ steroidal ADJ I-LF
1571
+ anti ADJ I-LF
1572
+ - ADJ I-LF
1573
+ inflammatory ADJ I-LF
1574
+ drugs NOUN I-LF
1575
+ , PUNCT O
1576
+ NSAIDs PROPN B-AC
1577
+ ) PUNCT O
1578
+ , PUNCT O
1579
+ diabetes NOUN O
1580
+ ( PUNCT O
1581
+ metformin NOUN O
1582
+ formulations NOUN O
1583
+ ) PUNCT O
1584
+ , PUNCT O
1585
+ depression NOUN O
1586
+ / SYM O
1587
+ anxiety NOUN O
1588
+ ( PUNCT O
1589
+ anti ADJ O
1590
+ - ADJ O
1591
+ depressant ADJ O
1592
+ / SYM O
1593
+ benzodiazepine NOUN O
1594
+ formulations NOUN O
1595
+ ) PUNCT O
1596
+ , PUNCT O
1597
+ and CCONJ O
1598
+ psychosis NOUN O
1599
+ ( PUNCT O
1600
+ anti ADJ O
1601
+ - ADJ O
1602
+ psychotic ADJ O
1603
+ formulations NOUN O
1604
+ ) PUNCT O
1605
+ in ADP O
1606
+ India PROPN O
1607
+ between ADP O
1608
+ 2007 NUM O
1609
+ and CCONJ O
1610
+ 2012 NUM O
1611
+ . PUNCT O
1612
+
1613
+ QEESI PROPN B-AC
1614
+ consisted VERB O
1615
+ of ADP O
1616
+ five NUM O
1617
+ subscales NOUN O
1618
+ , PUNCT O
1619
+ each PRON O
1620
+ with ADP O
1621
+ 10 NUM O
1622
+ items NOUN O
1623
+ , PUNCT O
1624
+ which PRON O
1625
+ in ADP O
1626
+ total NOUN O
1627
+ consisted VERB O
1628
+ of ADP O
1629
+ 50 NUM O
1630
+ items NOUN O
1631
+ : PUNCT O
1632
+ Q1 NOUN B-AC
1633
+ Chemical NOUN B-LF
1634
+ Intolerances NOUN I-LF
1635
+ , PUNCT O
1636
+ Q2 PROPN B-AC
1637
+ Other ADJ B-LF
1638
+ Intolerances NOUN I-LF
1639
+ , PUNCT O
1640
+ Q3 PROPN B-AC
1641
+ Symptom NOUN B-LF
1642
+ Severity PROPN I-LF
1643
+ , PUNCT O
1644
+ Q4 PROPN O
1645
+ Masking NOUN O
1646
+ Index PROPN O
1647
+ , PUNCT O
1648
+ and CCONJ O
1649
+ Q5 PROPN B-AC
1650
+ Life NOUN B-LF
1651
+ Impacts NOUN I-LF
1652
+ . PUNCT O
1653
+
1654
+ DD PROPN B-AC
1655
+ , PUNCT O
1656
+ constant ADJ B-LF
1657
+ darkness NOUN I-LF
1658
+ ; PUNCT O
1659
+ GI PROPN B-AC
1660
+ , PUNCT O
1661
+ GIGANTEA PROPN B-LF
1662
+ ; PUNCT O
1663
+ LUC PROPN B-AC
1664
+ , PUNCT O
1665
+ LUCIFERASE PROPN B-LF
1666
+ . PUNCT O
1667
+
1668
+ After ADP O
1669
+ 28 NUM O
1670
+ days NOUN O
1671
+ of ADP O
1672
+ treatment NOUN O
1673
+ , PUNCT O
1674
+ both CCONJ O
1675
+ the DET O
1676
+ low ADJ O
1677
+ ( PUNCT O
1678
+ 15 NUM O
1679
+ mg NOUN O
1680
+ / SYM O
1681
+ kg NOUN O
1682
+ b.w NOUN O
1683
+ . PUNCT O
1684
+ ) PUNCT O
1685
+ and CCONJ O
1686
+ medium ADJ O
1687
+ dose NOUN O
1688
+ ( PUNCT O
1689
+ 75 NUM O
1690
+ mg NOUN O
1691
+ / SYM O
1692
+ kg NOUN O
1693
+ b.w NOUN O
1694
+ . PUNCT O
1695
+ ) PUNCT O
1696
+ of ADP O
1697
+ SSJ PROPN B-AC
1698
+ prevented VERB O
1699
+ BW NOUN B-AC
1700
+ gain NOUN O
1701
+ but CCONJ O
1702
+ is AUX O
1703
+ more ADV O
1704
+ significant ADJ O
1705
+ with ADP O
1706
+ the DET O
1707
+ one NUM O
1708
+ dose NOUN O
1709
+ , PUNCT O
1710
+ leading VERB O
1711
+ to ADP O
1712
+ a DET O
1713
+ loss NOUN O
1714
+ of ADP O
1715
+ almost ADV O
1716
+ 5 NUM O
1717
+ g NOUN O
1718
+ in ADP O
1719
+ body NOUN B-LF
1720
+ weight NOUN I-LF
1721
+ ( PUNCT O
1722
+ P<0.01 NUM O
1723
+ ) PUNCT O
1724
+ compared VERB O
1725
+ to ADP O
1726
+ an DET O
1727
+ average NOUN O
1728
+ of ADP O
1729
+ 14.7 NUM O
1730
+ g NOUN O
1731
+ gained VERB O
1732
+ by ADP O
1733
+ the DET O
1734
+ HFD PROPN B-AC
1735
+ group NOUN O
1736
+ . PUNCT O
1737
+
1738
+ A DET O
1739
+ new ADJ O
1740
+ recently ADV O
1741
+ introduced VERB O
1742
+ anthropometric ADJ O
1743
+ measure NOUN O
1744
+ , PUNCT O
1745
+ named VERB O
1746
+ body NOUN B-LF
1747
+ shape NOUN I-LF
1748
+ index NOUN I-LF
1749
+ ( PUNCT O
1750
+ ABSI PROPN B-AC
1751
+ ) PUNCT O
1752
+ , PUNCT O
1753
+ appears VERB O
1754
+ to PART O
1755
+ be AUX O
1756
+ a DET O
1757
+ substantial ADJ O
1758
+ risk NOUN O
1759
+ factor NOUN O
1760
+ for ADP O
1761
+ premature ADJ O
1762
+ mortality NOUN O
1763
+ in ADP O
1764
+ the DET O
1765
+ general ADJ O
1766
+ population NOUN O
1767
+ [ PUNCT O
1768
+ 8 NUM O
1769
+ ] PUNCT O
1770
+ . PUNCT O
1771
+
1772
+ OPC PROPN B-AC
1773
+ , PUNCT O
1774
+ oligodendrocyte NOUN B-LF
1775
+ precursor NOUN I-LF
1776
+ cell NOUN I-LF
1777
+ ; PUNCT O
1778
+ UMAP PROPN B-AC
1779
+ , PUNCT O
1780
+ Uniform PROPN B-LF
1781
+ Manifold PROPN I-LF
1782
+ Approximation PROPN I-LF
1783
+ and CCONJ I-LF
1784
+ Projection PROPN I-LF
1785
+ . PUNCT O
1786
+
1787
+ Electrophysiological ADJ O
1788
+ methods NOUN O
1789
+ , PUNCT O
1790
+ like ADP O
1791
+ intracranially ADV O
1792
+ recorded VERB O
1793
+ electroencephalography NOUN B-LF
1794
+ ( PUNCT O
1795
+ EEG NOUN B-AC
1796
+ ) PUNCT O
1797
+ or CCONJ O
1798
+ EEG NOUN B-AC
1799
+ / SYM O
1800
+ magnetoencephalography NOUN B-LF
1801
+ ( PUNCT O
1802
+ MEG PROPN B-AC
1803
+ ) PUNCT O
1804
+ , PUNCT O
1805
+ are AUX O
1806
+ particularly ADV O
1807
+ promising ADJ O
1808
+ to PART O
1809
+ offer VERB O
1810
+ a DET O
1811
+ mechanistic ADJ O
1812
+ understanding NOUN O
1813
+ of ADP O
1814
+ memory NOUN O
1815
+ formation NOUN O
1816
+ processes NOUN O
1817
+ . PUNCT O
1818
+
1819
+ Patient NOUN O
1820
+ ( PUNCT O
1821
+ P NOUN O
1822
+ ) PUNCT O
1823
+ , PUNCT O
1824
+ Deletion NOUN B-LF
1825
+ of ADP I-LF
1826
+ exon NOUN I-LF
1827
+ 3 NUM I-LF
1828
+ of ADP O
1829
+ IL10RB PROPN O
1830
+ ( PUNCT O
1831
+ delE3 NOUN B-AC
1832
+ ) PUNCT O
1833
+ , PUNCT O
1834
+ duplication NOUN O
1835
+ of ADP O
1836
+ exon NOUN O
1837
+ 6 NUM O
1838
+ ( PUNCT O
1839
+ duplE6 NOUN O
1840
+ ) PUNCT O
1841
+ , PUNCT O
1842
+ and CCONJ O
1843
+ wild ADJ O
1844
+ type NOUN O
1845
+ allele NOUN O
1846
+ ( PUNCT O
1847
+ WT NOUN O
1848
+ ) PUNCT O
1849
+ . PUNCT O
1850
+ Allele PROPN O
1851
+ 1 NUM O
1852
+ ; PUNCT O
1853
+ maternal ADJ O
1854
+ allele NOUN O
1855
+ , PUNCT O
1856
+ Allele PROPN O
1857
+ 2 NUM O
1858
+ , PUNCT O
1859
+ paternal ADJ O
1860
+ allele NOUN O
1861
+ ( PUNCT O
1862
+ see VERB O
1863
+ S2 PROPN O
1864
+ Fig PROPN O
1865
+ ) PUNCT O
1866
+ . PUNCT O
1867
+
1868
+ Abbreviations NOUN O
1869
+ : PUNCT O
1870
+ HOMA PROPN B-AC
1871
+ - PUNCT B-AC
1872
+ IR PROPN B-AC
1873
+ , PUNCT O
1874
+ HOMA PROPN O
1875
+ Insulin PROPN B-LF
1876
+ Resistance PROPN I-LF
1877
+ Index PROPN O
1878
+ ; PUNCT O
1879
+ ESS PROPN B-AC
1880
+ , PUNCT O
1881
+ Epworth PROPN B-LF
1882
+ Sleepiness PROPN I-LF
1883
+ Scale PROPN I-LF
1884
+ ; PUNCT O
1885
+ MSLT PROPN B-AC
1886
+ , PUNCT O
1887
+ multiple ADJ O
1888
+ sleep NOUN O
1889
+ latency NOUN O
1890
+ test NOUN O
1891
+ ; PUNCT O
1892
+ TST PROPN B-AC
1893
+ , PUNCT O
1894
+ total ADJ B-LF
1895
+ sleep NOUN I-LF
1896
+ time NOUN I-LF
1897
+ ; PUNCT O
1898
+ SOL PROPN B-AC
1899
+ , PUNCT O
1900
+ sleep NOUN B-LF
1901
+ onset NOUN I-LF
1902
+ latency NOUN I-LF
1903
+ ; PUNCT O
1904
+ WASO PROPN B-AC
1905
+ , PUNCT O
1906
+ waking VERB B-LF
1907
+ after ADP I-LF
1908
+ sleep NOUN I-LF
1909
+ onset NOUN I-LF
1910
+ ; PUNCT O
1911
+ REM PROPN B-AC
1912
+ , PUNCT O
1913
+ rapid ADJ B-LF
1914
+ eyes NOUN I-LF
1915
+ movement NOUN I-LF
1916
+ ; PUNCT O
1917
+ AHI PROPN B-AC
1918
+ , PUNCT O
1919
+ apnea NOUN O
1920
+ - PUNCT O
1921
+ hypopnea NOUN O
1922
+ index NOUN O
1923
+ . PUNCT O
1924
+
1925
+ In ADP O
1926
+ this DET O
1927
+ study NOUN O
1928
+ , PUNCT O
1929
+ the DET B-LF
1930
+ peel NOUN I-LF
1931
+ of ADP I-LF
1932
+ green ADJ I-LF
1933
+ fruit NOUN I-LF
1934
+ ( PUNCT O
1935
+ GFP PROPN B-AC
1936
+ ) PUNCT O
1937
+ , PUNCT O
1938
+ the DET B-LF
1939
+ sarcocarp NOUN I-LF
1940
+ of ADP I-LF
1941
+ green ADJ I-LF
1942
+ fruit NOUN I-LF
1943
+ ( PUNCT O
1944
+ GFS PROPN B-AC
1945
+ ) PUNCT O
1946
+ , PUNCT O
1947
+ the DET B-LF
1948
+ peel NOUN I-LF
1949
+ of ADP I-LF
1950
+ red ADJ I-LF
1951
+ fruit NOUN I-LF
1952
+ ( PUNCT O
1953
+ FP PROPN B-AC
1954
+ ) PUNCT O
1955
+ and CCONJ O
1956
+ the DET B-LF
1957
+ sarcocarp NOUN I-LF
1958
+ of ADP I-LF
1959
+ red ADJ I-LF
1960
+ fruit NOUN I-LF
1961
+ ( PUNCT O
1962
+ FS PROPN B-AC
1963
+ ) PUNCT O
1964
+ of ADP O
1965
+ G. PROPN O
1966
+ jasminoides NOUN O
1967
+ were AUX O
1968
+ used VERB O
1969
+ for ADP O
1970
+ transcriptome NOUN O
1971
+ sequencing NOUN O
1972
+ . PUNCT O
1973
+
1974
+ Studies NOUN O
1975
+ show VERB O
1976
+ that SCONJ O
1977
+ in ADP O
1978
+ chronic ADJ O
1979
+ liver NOUN O
1980
+ disease NOUN O
1981
+ , PUNCT O
1982
+ proinflammatory ADJ O
1983
+ cytokines NOUN O
1984
+ such ADJ O
1985
+ as ADP O
1986
+ TNF PROPN B-AC
1987
+ - PUNCT B-AC
1988
+ α NOUN B-AC
1989
+ , PUNCT O
1990
+ IL-1β NOUN O
1991
+ and CCONJ O
1992
+ PDGF PROPN B-AC
1993
+ ( PUNCT O
1994
+ platelet NOUN B-LF
1995
+ - PUNCT I-LF
1996
+ derived VERB I-LF
1997
+ growth NOUN I-LF
1998
+ factor NOUN I-LF
1999
+ ) PUNCT O
2000
+ stimulate VERB O
2001
+ the DET O
2002
+ secretion NOUN O
2003
+ of ADP O
2004
+ SDF-1 NOUN B-AC
2005
+ by ADP O
2006
+ hepatocytes NOUN O
2007
+ in ADP O
2008
+ the DET O
2009
+ tissue NOUN O
2010
+ [ PUNCT O
2011
+ 20,21 NUM O
2012
+ ] PUNCT O
2013
+ . PUNCT O
2014
+
2015
+ Atomic ADJ O
2016
+ coordinates NOUN O
2017
+ and CCONJ O
2018
+ structure NOUN O
2019
+ factors NOUN O
2020
+ were AUX O
2021
+ deposited VERB O
2022
+ in ADP O
2023
+ the DET O
2024
+ Protein PROPN B-LF
2025
+ Data PROPN I-LF
2026
+ Bank PROPN I-LF
2027
+ under ADP O
2028
+ PDB PROPN B-AC
2029
+ i NOUN O
2030
+ d NOUN O
2031
+ code NOUN O
2032
+ 5HSA NOUN O
2033
+ . PUNCT O
2034
+
2035
+ The DET O
2036
+ RNA NOUN O
2037
+ mimic NOUN O
2038
+ we PRON O
2039
+ utilized VERB O
2040
+ comprises VERB O
2041
+ the DET O
2042
+ ITS1 PROPN O
2043
+ sequence NOUN O
2044
+ , PUNCT O
2045
+ which PRON O
2046
+ forms VERB O
2047
+ the DET O
2048
+ main ADJ O
2049
+ binding VERB O
2050
+ site NOUN O
2051
+ between ADP O
2052
+ Rrp5 NOUN O
2053
+ and CCONJ O
2054
+ preribosomes NOUN O
2055
+ ( PUNCT O
2056
+ S1B PROPN O
2057
+ Fig PROPN O
2058
+ , PUNCT O
2059
+ [ NUM O
2060
+ 12,13 NUM O
2061
+ ] PUNCT O
2062
+ ) PUNCT O
2063
+ . PUNCT O
2064
+ 3 NUM B-AC
2065
+ - PUNCT B-AC
2066
+ D NOUN B-AC
2067
+ reconstruction NOUN O
2068
+ of ADP O
2069
+ the DET O
2070
+ density NOUN O
2071
+ observed VERB O
2072
+ for ADP O
2073
+ the DET O
2074
+ complex NOUN O
2075
+ between ADP O
2076
+ Rrp5 NOUN O
2077
+ and CCONJ O
2078
+ RNA NOUN O
2079
+ ( PUNCT O
2080
+ Rrp5•RNA NOUN B-AC
2081
+ ) PUNCT O
2082
+ ( PUNCT O
2083
+ EM PROPN B-AC
2084
+ Database PROPN O
2085
+ code NOUN O
2086
+ 6655 NUM O
2087
+ ) PUNCT O
2088
+ shows VERB O
2089
+ an DET O
2090
+ elongated ADJ O
2091
+ molecule NOUN O
2092
+ with ADP O
2093
+ a DET O
2094
+ round ADJ O
2095
+ , PUNCT O
2096
+ hollow ADJ O
2097
+ fist NOUN O
2098
+ - PUNCT O
2099
+ like ADJ O
2100
+ base NOUN O
2101
+ and CCONJ O
2102
+ a DET O
2103
+ slender ADJ O
2104
+ thumb NOUN O
2105
+ - PUNCT O
2106
+ like ADJ O
2107
+ projection NOUN O
2108
+ ( PUNCT O
2109
+ Fig PROPN O
2110
+ 4B NUM O
2111
+ ) PUNCT O
2112
+ . PUNCT O
2113
+ 2 NUM B-AC
2114
+ - PUNCT B-AC
2115
+ D NOUN B-AC
2116
+ alignment NOUN O
2117
+ and CCONJ O
2118
+ classification NOUN O
2119
+ and CCONJ O
2120
+ 3 NUM B-AC
2121
+ - PUNCT B-AC
2122
+ D NOUN B-AC
2123
+ analysis NOUN O
2124
+ by ADP O
2125
+ random ADJ B-LF
2126
+ conical ADJ I-LF
2127
+ tilt NOUN I-LF
2128
+ ( PUNCT O
2129
+ RCT PROPN B-AC
2130
+ ) PUNCT O
2131
+ confirm VERB O
2132
+ this DET O
2133
+ assessment NOUN O
2134
+ ( PUNCT O
2135
+ S5 PROPN O
2136
+ Fig PROPN O
2137
+ ) PUNCT O
2138
+ . PUNCT O
2139
+
2140
+ At ADP O
2141
+ 24 NUM O
2142
+ hpi NOUN B-AC
2143
+ , PUNCT O
2144
+ we PRON O
2145
+ euthanized VERB O
2146
+ embryos NOUN O
2147
+ and CCONJ O
2148
+ determined VERB O
2149
+ bacterial ADJ O
2150
+ burden NOUN O
2151
+ ( PUNCT O
2152
+ colony NOUN B-LF
2153
+ - PUNCT I-LF
2154
+ forming VERB I-LF
2155
+ units NOUN I-LF
2156
+ [ PUNCT O
2157
+ CFU PROPN B-AC
2158
+ ] PUNCT O
2159
+ ) PUNCT O
2160
+ in ADP O
2161
+ whole ADJ O
2162
+ fish NOUN O
2163
+ . PUNCT O
2164
+
2165
+ In ADP O
2166
+ our PRON O
2167
+ expedition NOUN O
2168
+ to ADP O
2169
+ characterize VERB O
2170
+ membrane NOUN O
2171
+ biogenesis NOUN O
2172
+ in ADP O
2173
+ T. PROPN O
2174
+ gondii PROPN O
2175
+ , PUNCT O
2176
+ we PRON O
2177
+ fractionated VERB O
2178
+ the DET O
2179
+ parasite NOUN O
2180
+ lipids NOUN O
2181
+ by ADP O
2182
+ high ADJ O
2183
+ - PUNCT O
2184
+ performance NOUN O
2185
+ liquid NOUN O
2186
+ chromatography NOUN O
2187
+ ( PUNCT O
2188
+ HPLC PROPN B-AC
2189
+ ) PUNCT O
2190
+ and CCONJ O
2191
+ observed VERB O
2192
+ a DET O
2193
+ major ADJ O
2194
+ lipid NOUN O
2195
+ peak NOUN O
2196
+ X1 NUM O
2197
+ eluting VERB O
2198
+ next ADV O
2199
+ to ADP O
2200
+ PtdSer PROPN B-AC
2201
+ ( PUNCT O
2202
+ Fig PROPN O
2203
+ 1A NUM O
2204
+ ) PUNCT O
2205
+ . PUNCT O
2206
+ Other ADJ O
2207
+ major ADJ O
2208
+ lipids NOUN O
2209
+ were AUX O
2210
+ PtdCho PROPN B-AC
2211
+ , PUNCT O
2212
+ PtdEtn PROPN B-AC
2213
+ , PUNCT O
2214
+ PtdIns PROPN B-AC
2215
+ , PUNCT O
2216
+ PtdSer PROPN B-AC
2217
+ , PUNCT O
2218
+ and CCONJ O
2219
+ phosphoethanolamine NOUN B-LF
2220
+ - PUNCT I-LF
2221
+ ceramide NOUN I-LF
2222
+ ( PUNCT O
2223
+ PEtn PROPN B-AC
2224
+ - PUNCT B-AC
2225
+ Cer PROPN B-AC
2226
+ ) PUNCT O
2227
+ , PUNCT O
2228
+ confirming VERB O
2229
+ previous ADJ O
2230
+ reports NOUN O
2231
+ [ X O
2232
+ 5,7 NUM O
2233
+ ] PUNCT O
2234
+ . PUNCT O
2235
+
2236
+ The DET O
2237
+ first ADJ O
2238
+ layer NOUN O
2239
+ line NOUN O
2240
+ indicates VERB O
2241
+ the DET O
2242
+ 111 NUM O
2243
+ - PUNCT O
2244
+ Å NOUN O
2245
+ helical ADJ O
2246
+ pitch NOUN O
2247
+ of ADP O
2248
+ the DET O
2249
+ WT PROPN B-AC
2250
+ - PUNCT B-AC
2251
+ M1 PROPN B-AC
2252
+ oligomer NOUN O
2253
+ . PUNCT O
2254
+ ( PUNCT O
2255
+ C NOUN O
2256
+ ) PUNCT O
2257
+ 2D ADJ O
2258
+ class NOUN O
2259
+ averages NOUN O
2260
+ that PRON O
2261
+ focus VERB O
2262
+ on ADP O
2263
+ the DET O
2264
+ center NOUN O
2265
+ of ADP O
2266
+ the DET O
2267
+ helical ADJ O
2268
+ segments NOUN O
2269
+ show VERB O
2270
+ large ADJ O
2271
+ heterogeneity NOUN O
2272
+ of ADP O
2273
+ additional ADJ O
2274
+ density NOUN O
2275
+ on ADP O
2276
+ either DET O
2277
+ side NOUN O
2278
+ of ADP O
2279
+ the DET O
2280
+ outer ADJ O
2281
+ layer NOUN O
2282
+ of ADP O
2283
+ the DET O
2284
+ filament NOUN O
2285
+ . PUNCT O
2286
+ cryo ADJ B-AC
2287
+ - PUNCT B-AC
2288
+ EM PROPN B-AC
2289
+ , PUNCT O
2290
+ cryo ADJ B-LF
2291
+ - PUNCT I-LF
2292
+ electron NOUN I-LF
2293
+ microscopy NOUN I-LF
2294
+ ; PUNCT O
2295
+ M1 PROPN B-AC
2296
+ , PUNCT O
2297
+ matrix NOUN B-LF
2298
+ protein NOUN I-LF
2299
+ 1 NUM I-LF
2300
+ ; PUNCT O
2301
+ WT PROPN B-AC
2302
+ - PUNCT B-AC
2303
+ M1 PROPN B-AC
2304
+ , PUNCT O
2305
+ full ADJ B-LF
2306
+ - PUNCT I-LF
2307
+ length NOUN I-LF
2308
+ PR8 PROPN I-LF
2309
+ M1 PROPN I-LF
2310
+ . PUNCT O
2311
+
2312
+ HP PROPN B-AC
2313
+ , PUNCT O
2314
+ hippocampus NOUN B-LF
2315
+ ; PUNCT O
2316
+ LEC PROPN B-AC
2317
+ , PUNCT O
2318
+ lateral ADJ B-LF
2319
+ entorhinal ADJ I-LF
2320
+ cortex NOUN I-LF
2321
+ ; PUNCT O
2322
+ MTC PROPN B-AC
2323
+ , PUNCT O
2324
+ mitral ADJ B-LF
2325
+ and CCONJ I-LF
2326
+ tufted ADJ I-LF
2327
+ cell NOUN I-LF
2328
+ ; PUNCT O
2329
+ OB PROPN B-AC
2330
+ , PUNCT O
2331
+ olfactory ADJ B-LF
2332
+ bulb NOUN I-LF
2333
+ ; PUNCT O
2334
+ PFC PROPN B-AC
2335
+ , PUNCT O
2336
+ prefrontal ADJ B-LF
2337
+ cortex NOUN I-LF
2338
+ ; PUNCT O
2339
+ RR NOUN B-AC
2340
+ , PUNCT O
2341
+ respiration NOUN B-LF
2342
+ - PUNCT I-LF
2343
+ related VERB I-LF
2344
+ rhythm NOUN I-LF
2345
+ . PUNCT O
2346
+
2347
+ The DET O
2348
+ histone NOUN B-LF
2349
+ deacetylase NOUN I-LF
2350
+ 1 NUM I-LF
2351
+ ( PUNCT O
2352
+ HDAC1 NOUN B-AC
2353
+ ) PUNCT O
2354
+ was AUX O
2355
+ used VERB O
2356
+ as ADP O
2357
+ a DET O
2358
+ loading NOUN O
2359
+ control NOUN O
2360
+ . PUNCT O
2361
+
2362
+ In ADP O
2363
+ the DET O
2364
+ models NOUN O
2365
+ presented VERB O
2366
+ here ADV O
2367
+ , PUNCT O
2368
+ weight NOUN B-LF
2369
+ - PUNCT I-LF
2370
+ for ADP I-LF
2371
+ - PUNCT I-LF
2372
+ length NOUN I-LF
2373
+ - PUNCT I-LF
2374
+ z NOUN I-LF
2375
+ - PUNCT I-LF
2376
+ scores NOUN I-LF
2377
+ ( PUNCT O
2378
+ WLZs NOUN B-AC
2379
+ ) PUNCT O
2380
+ were AUX O
2381
+ used VERB O
2382
+ . PUNCT O
2383
+
2384
+ In ADP O
2385
+ order NOUN O
2386
+ to PART O
2387
+ identify VERB O
2388
+ essential ADJ O
2389
+ genes NOUN O
2390
+ on ADP O
2391
+ the DET O
2392
+ X NOUN O
2393
+ chromosome NOUN O
2394
+ that PRON O
2395
+ are AUX O
2396
+ involved ADJ O
2397
+ in ADP O
2398
+ neuronal ADJ O
2399
+ homeostasis NOUN O
2400
+ , PUNCT O
2401
+ we PRON O
2402
+ performed VERB O
2403
+ a DET O
2404
+ forward ADJ O
2405
+ genetic ADJ O
2406
+ screen NOUN O
2407
+ using VERB O
2408
+ ethyl NOUN B-LF
2409
+ methanesulfonate NOUN I-LF
2410
+ ( PUNCT O
2411
+ EMS PROPN B-AC
2412
+ ) PUNCT O
2413
+ . PUNCT O
2414
+ We PRON O
2415
+ used VERB O
2416
+ the DET O
2417
+ FLP PROPN O
2418
+ / SYM O
2419
+ FRT PROPN O
2420
+ system NOUN O
2421
+ to PART O
2422
+ induce VERB O
2423
+ homozygous ADJ O
2424
+ mutant ADJ O
2425
+ clones NOUN O
2426
+ in ADP O
2427
+ the DET O
2428
+ photoreceptor NOUN O
2429
+ neurons NOUN O
2430
+ of ADP O
2431
+ the DET O
2432
+ otherwise ADV O
2433
+ heterozygous ADJ O
2434
+ flies NOUN O
2435
+ and CCONJ O
2436
+ performed VERB O
2437
+ electroretinograms NOUN B-LF
2438
+ ( PUNCT O
2439
+ ERGs PROPN B-AC
2440
+ ) PUNCT O
2441
+ on ADP O
2442
+ 3- NUM O
2443
+ and CCONJ O
2444
+ 33 NUM O
2445
+ - PUNCT O
2446
+ days NOUN O
2447
+ - PUNCT O
2448
+ old ADJ O
2449
+ flies NOUN O
2450
+ . PUNCT O
2451
+
2452
+ Secondary ADJ O
2453
+ results NOUN O
2454
+ included VERB O
2455
+ spherical ADJ B-LF
2456
+ equivalent NOUN I-LF
2457
+ ( PUNCT O
2458
+ SE PROPN B-AC
2459
+ ) PUNCT O
2460
+ and CCONJ O
2461
+ CCT PROPN B-AC
2462
+ . PUNCT O
2463
+ Finally ADV O
2464
+ , PUNCT O
2465
+ ECD PROPN B-AC
2466
+ and CCONJ O
2467
+ IOP PROPN O
2468
+ were AUX O
2469
+ set VERB O
2470
+ as ADP O
2471
+ the DET O
2472
+ last ADJ O
2473
+ observation NOUN O
2474
+ indicator NOUN O
2475
+ to PART O
2476
+ evaluate VERB O
2477
+ the DET O
2478
+ safety NOUN O
2479
+ of ADP O
2480
+ surgery NOUN O
2481
+ . PUNCT O
2482
+
2483
+ HILIC PROPN B-AC
2484
+ - PUNCT B-AC
2485
+ MS2 PROPN B-AC
2486
+ of ADP O
2487
+ stereo ADV O
2488
+ - PUNCT O
2489
+ controlled VERB O
2490
+ β NOUN B-AC
2491
+ - PUNCT B-AC
2492
+ GlcCer PROPN B-AC
2493
+ and CCONJ O
2494
+ an DET O
2495
+ α NOUN O
2496
+ / SYM O
2497
+ β NOUN B-AC
2498
+ - PUNCT B-AC
2499
+ GlcCer PROPN B-AC
2500
+ mixture NOUN O
2501
+ . PUNCT O
2502
+ α NOUN O
2503
+ / SYM O
2504
+ β NOUN B-AC
2505
+ - PUNCT B-AC
2506
+ GlcCer PROPN B-AC
2507
+ , PUNCT O
2508
+ α NOUN O
2509
+ / SYM O
2510
+ β NOUN B-LF
2511
+ - PUNCT I-LF
2512
+ glucosylceramide NOUN I-LF
2513
+ ; PUNCT O
2514
+ HILIC PROPN B-AC
2515
+ - PUNCT B-AC
2516
+ MS2 PROPN B-AC
2517
+ , PUNCT O
2518
+ hydrophilic ADJ B-LF
2519
+ interaction NOUN I-LF
2520
+ liquid NOUN I-LF
2521
+ chromatography NOUN I-LF
2522
+ - PUNCT I-LF
2523
+ tandem NOUN I-LF
2524
+ mass NOUN I-LF
2525
+ spectrometry NOUN I-LF
2526
+ . PUNCT O
2527
+
2528
+ COTS PROPN B-AC
2529
+ , PUNCT O
2530
+ crown NOUN B-LF
2531
+ - PUNCT I-LF
2532
+ of ADP I-LF
2533
+ - PUNCT I-LF
2534
+ thorns NOUN I-LF
2535
+ starfish NOUN I-LF
2536
+ ; PUNCT O
2537
+ GBR PROPN B-AC
2538
+ , PUNCT O
2539
+ Great PROPN B-LF
2540
+ Barrier PROPN I-LF
2541
+ Reef PROPN I-LF
2542
+ ; PUNCT O
2543
+ NCJ PROPN O
2544
+ , PUNCT O
2545
+ North PROPN O
2546
+ Caledonian PROPN O
2547
+ Jet PROPN O
2548
+ ; PUNCT O
2549
+ SCJ PROPN O
2550
+ , PUNCT O
2551
+ South PROPN O
2552
+ Caledonian PROPN O
2553
+ Jet PROPN O
2554
+ . PUNCT O
2555
+
2556
+ We PRON O
2557
+ mechanistically ADV O
2558
+ studied VERB O
2559
+ tTreg NOUN B-AC
2560
+ cell NOUN O
2561
+ generation NOUN O
2562
+ in ADP O
2563
+ the DET O
2564
+ atrophied ADJ O
2565
+ thymus NOUN O
2566
+ by ADP O
2567
+ utilizing VERB O
2568
+ both CCONJ O
2569
+ postnatal ADJ O
2570
+ TEC NOUN B-AC
2571
+ - PUNCT O
2572
+ defective ADJ O
2573
+ ( PUNCT O
2574
+ resulting VERB O
2575
+ from ADP O
2576
+ FoxN1 PROPN B-AC
2577
+ - PUNCT O
2578
+ floxed VERB O
2579
+ conditional ADJ B-LF
2580
+ knockout NOUN I-LF
2581
+ [ X O
2582
+ cKO NOUN B-AC
2583
+ ] PUNCT O
2584
+ ) PUNCT O
2585
+ and CCONJ O
2586
+ naturally ADV O
2587
+ aged VERB O
2588
+ mouse NOUN O
2589
+ models NOUN O
2590
+ . PUNCT O
2591
+
2592
+ A DET O
2593
+ switch NOUN O
2594
+ of ADP O
2595
+ this DET O
2596
+ balance NOUN O
2597
+ to ADP O
2598
+ the DET O
2599
+ benefit NOUN O
2600
+ of ADP O
2601
+ augmented VERB O
2602
+ responses NOUN O
2603
+ toward ADP O
2604
+ TGFβ NOUN B-AC
2605
+ is AUX O
2606
+ a DET O
2607
+ hallmark NOUN O
2608
+ of ADP O
2609
+ endothelial ADJ B-LF
2610
+ cell NOUN I-LF
2611
+ ( PUNCT O
2612
+ EC PROPN B-AC
2613
+ ) PUNCT O
2614
+ dysfunction NOUN O
2615
+ and CCONJ O
2616
+ precondition NOUN O
2617
+ to ADP O
2618
+ several ADJ O
2619
+ vascular ADJ O
2620
+ diseases NOUN O
2621
+ , PUNCT O
2622
+ including VERB O
2623
+ cerebral ADJ B-LF
2624
+ cavernous ADJ I-LF
2625
+ malformation NOUN I-LF
2626
+ ( PUNCT O
2627
+ CCM PROPN B-AC
2628
+ ) PUNCT O
2629
+ [ PUNCT O
2630
+ 2 NUM O
2631
+ ] PUNCT O
2632
+ , PUNCT O
2633
+ hereditary ADJ B-LF
2634
+ hemorrhagic ADJ I-LF
2635
+ telangiectasia NOUN I-LF
2636
+ ( PUNCT O
2637
+ HHT PROPN B-AC
2638
+ ) PUNCT O
2639
+ [ PUNCT O
2640
+ 3 NUM O
2641
+ ] PUNCT O
2642
+ , PUNCT O
2643
+ and CCONJ O
2644
+ pulmonary ADJ B-LF
2645
+ arterial ADJ I-LF
2646
+ hypertension NOUN I-LF
2647
+ ( PUNCT O
2648
+ PAH PROPN B-AC
2649
+ ) PUNCT O
2650
+ . PUNCT O
2651
+ Understanding VERB O
2652
+ the DET O
2653
+ cellular ADJ O
2654
+ context NOUN O
2655
+ in ADP O
2656
+ which PRON O
2657
+ this DET O
2658
+ imbalance NOUN O
2659
+ takes VERB O
2660
+ place NOUN O
2661
+ is AUX O
2662
+ key ADJ O
2663
+ to ADP O
2664
+ tackling VERB O
2665
+ augmented VERB O
2666
+ TGFβ NOUN B-AC
2667
+ signaling NOUN O
2668
+ [ PUNCT O
2669
+ 4 NUM O
2670
+ ] PUNCT O
2671
+ . PUNCT O
2672
+
2673
+ ACE2 PROPN B-AC
2674
+ , PUNCT O
2675
+ angiotensin NOUN B-LF
2676
+ - PUNCT I-LF
2677
+ converting VERB I-LF
2678
+ enzyme NOUN I-LF
2679
+ 2 NUM I-LF
2680
+ ; PUNCT O
2681
+ RBD PROPN B-AC
2682
+ , PUNCT O
2683
+ receptor NOUN B-LF
2684
+ binding VERB I-LF
2685
+ domain NOUN I-LF
2686
+ ; PUNCT O
2687
+ SARS PROPN B-AC
2688
+ - PUNCT B-AC
2689
+ CoV-2 PROPN B-AC
2690
+ , PUNCT O
2691
+ SARS PROPN B-LF
2692
+ Coronavirus PROPN I-LF
2693
+ 2 NUM I-LF
2694
+ . PUNCT O
2695
+
2696
+ CIDRZ PROPN B-AC
2697
+ , PUNCT O
2698
+ Centre PROPN B-LF
2699
+ for ADP I-LF
2700
+ Infectious PROPN I-LF
2701
+ Disease PROPN I-LF
2702
+ Research PROPN I-LF
2703
+ in ADP I-LF
2704
+ Zambia PROPN I-LF
2705
+ ; PUNCT O
2706
+ LTFU PROPN O
2707
+ , PUNCT O
2708
+ lost VERB O
2709
+ to ADP O
2710
+ follow NOUN O
2711
+ - PUNCT O
2712
+ up NOUN O
2713
+ ; PUNCT O
2714
+ PPS PROPN O
2715
+ , PUNCT O
2716
+ probability NOUN O
2717
+ proportional ADJ O
2718
+ to ADP O
2719
+ size NOUN O
2720
+ ; PUNCT O
2721
+ SRS PROPN O
2722
+ , PUNCT O
2723
+ simple ADJ O
2724
+ random ADJ O
2725
+ sample NOUN O
2726
+ . PUNCT O
2727
+
2728
+ Thoracolumbar ADJ B-LF
2729
+ interfascial ADJ I-LF
2730
+ block NOUN I-LF
2731
+ ( PUNCT O
2732
+ TLIP NOUN B-AC
2733
+ block NOUN B-AC
2734
+ ) PUNCT O
2735
+ is AUX O
2736
+ a DET O
2737
+ novel ADJ O
2738
+ regional ADJ O
2739
+ anesthesia NOUN O
2740
+ technique NOUN O
2741
+ first ADV O
2742
+ described VERB O
2743
+ by ADP O
2744
+ Hand PROPN O
2745
+ et NOUN O
2746
+ al NOUN O
2747
+ . PUNCT O
2748
+ in ADP O
2749
+ 2015 NUM O
2750
+ [ PUNCT O
2751
+ 7 NUM O
2752
+ ] PUNCT O
2753
+ , PUNCT O
2754
+ which PRON O
2755
+ is AUX O
2756
+ an DET O
2757
+ interfascial ADJ O
2758
+ plane NOUN O
2759
+ block NOUN O
2760
+ applied VERB O
2761
+ at ADP O
2762
+ the DET O
2763
+ L3 NOUN O
2764
+ vertebral ADJ O
2765
+ level NOUN O
2766
+ in ADP O
2767
+ spine NOUN O
2768
+ surgery NOUN O
2769
+ . PUNCT O
2770
+
2771
+ Abbreviations NOUN O
2772
+ : PUNCT O
2773
+ ACE PROPN B-AC
2774
+ , PUNCT O
2775
+ adverse ADJ B-LF
2776
+ childhood NOUN I-LF
2777
+ experience NOUN I-LF
2778
+ ; PUNCT O
2779
+ CI PROPN B-AC
2780
+ , PUNCT O
2781
+ confidence NOUN B-LF
2782
+ interval NOUN I-LF
2783
+ ; PUNCT O
2784
+ CSE PROPN O
2785
+ , PUNCT O
2786
+ Certificate PROPN O
2787
+ of ADP O
2788
+ Secondary PROPN O
2789
+ Education PROPN O
2790
+ ; PUNCT O
2791
+ GCSE PROPN B-AC
2792
+ , PUNCT O
2793
+ General PROPN B-LF
2794
+ Certificate PROPN I-LF
2795
+ of ADP I-LF
2796
+ Secondary PROPN I-LF
2797
+ Education PROPN I-LF
2798
+ ; PUNCT O
2799
+ PAF PROPN O
2800
+ , PUNCT O
2801
+ population NOUN O
2802
+ attributable ADJ O
2803
+ fraction NOUN O
2804
+ ; PUNCT O
2805
+ RD PROPN B-AC
2806
+ , PUNCT O
2807
+ risk NOUN B-LF
2808
+ difference NOUN I-LF
2809
+ . PUNCT O
2810
+
2811
+ BMI NOUN B-AC
2812
+ = VERB O
2813
+ body NOUN B-LF
2814
+ mass NOUN I-LF
2815
+ index NOUN I-LF
2816
+ ; PUNCT O
2817
+ MET PROPN B-AC
2818
+ = VERB O
2819
+ metabolic ADJ B-LF
2820
+ equivalent NOUN I-LF
2821
+
2822
+ Isolates NOUN O
2823
+ were AUX O
2824
+ cultured VERB O
2825
+ from ADP O
2826
+ sputum NOUN O
2827
+ or CCONJ O
2828
+ bronchoalveolar ADJ B-LF
2829
+ lavage NOUN I-LF
2830
+ ( PUNCT O
2831
+ BAL NOUN B-AC
2832
+ ) PUNCT O
2833
+ from ADP O
2834
+ patients NOUN O
2835
+ with ADP O
2836
+ CF PROPN B-AC
2837
+ after ADP O
2838
+ obtaining VERB O
2839
+ informed ADJ O
2840
+ consent NOUN O
2841
+ . PUNCT O
2842
+
2843
+ Reviewer ADJ O
2844
+ comment NOUN O
2845
+ : PUNCT O
2846
+ 13 X O
2847
+ . X O
2848
+ “ PUNCT O
2849
+ Table NOUN O
2850
+ 4 NUM O
2851
+ : PUNCT O
2852
+ Bivariate ADJ O
2853
+ and CCONJ O
2854
+ Multivariate ADJ O
2855
+ analysis NOUN O
2856
+ on ADP O
2857
+ treatment NOUN O
2858
+ outcome NOUN O
2859
+ of ADP O
2860
+ SAM PROPN B-AC
2861
+ and CCONJ O
2862
+ associated VERB O
2863
+ factors NOUN O
2864
+ ” PUNCT O
2865
+ shall AUX O
2866
+ be AUX O
2867
+ re VERB O
2868
+ - VERB O
2869
+ written VERB O
2870
+ as ADP O
2871
+ “ PUNCT O
2872
+ Table NOUN O
2873
+ 4 NUM O
2874
+ : PUNCT O
2875
+ Treatment NOUN O
2876
+ outcome NOUN O
2877
+ of ADP O
2878
+ severe ADJ B-LF
2879
+ acute ADJ I-LF
2880
+ malnutrition NOUN I-LF
2881
+ and CCONJ O
2882
+ associated VERB O
2883
+ factors NOUN O
2884
+ in ADP O
2885
+ ------ PUNCT O
2886
+ Woreda PROPN O
2887
+ , PUNCT O
2888
+ Northern PROPN O
2889
+ Wollo PROPN O
2890
+ , PUNCT O
2891
+ Ethiopia PROPN O
2892
+ ---month NOUN O
2893
+ , PUNCT O
2894
+ ----year NOUN O
2895
+ to ADP O
2896
+ -----month NOUN O
2897
+ , PUNCT O
2898
+ ----year NOUN O
2899
+ ” PUNCT O
2900
+
2901
+ Dual ADJ B-LF
2902
+ - PUNCT I-LF
2903
+ specificity NOUN I-LF
2904
+ tyrosine NOUN I-LF
2905
+ - PUNCT I-LF
2906
+ phosphorylation NOUN I-LF
2907
+ - PUNCT I-LF
2908
+ regulated VERB I-LF
2909
+ kinase NOUN I-LF
2910
+ 2 NUM I-LF
2911
+ ( PUNCT O
2912
+ DYRK2 PROPN B-AC
2913
+ ) PUNCT O
2914
+ is AUX O
2915
+ a DET O
2916
+ member NOUN O
2917
+ of ADP O
2918
+ dual ADJ O
2919
+ - PUNCT O
2920
+ specificity NOUN O
2921
+ kinase NOUN O
2922
+ family NOUN O
2923
+ , PUNCT O
2924
+ which PRON O
2925
+ could AUX O
2926
+ phosphorylate VERB O
2927
+ both CCONJ O
2928
+ Ser PROPN O
2929
+ / SYM O
2930
+ Thr PROPN O
2931
+ and CCONJ O
2932
+ Tyr PROPN O
2933
+ substrates NOUN O
2934
+ . PUNCT O
2935
+
2936
+ Damage NOUN B-LF
2937
+ - PUNCT I-LF
2938
+ associated VERB I-LF
2939
+ molecular ADJ I-LF
2940
+ patterns NOUN I-LF
2941
+ ( PUNCT O
2942
+ DAMPs PROPN B-AC
2943
+ ) PUNCT O
2944
+ are AUX O
2945
+ released VERB O
2946
+ into ADP O
2947
+ the DET O
2948
+ extracellular ADJ O
2949
+ space NOUN O
2950
+ by ADP O
2951
+ tissue NOUN O
2952
+ damage NOUN O
2953
+ that PRON O
2954
+ triggers VERB O
2955
+ an DET O
2956
+ inflammatory ADJ O
2957
+ response NOUN O
2958
+ without ADP O
2959
+ infection NOUN O
2960
+ . PUNCT O
2961
+
2962
+ Other ADJ O
2963
+ outcomes NOUN O
2964
+ included VERB O
2965
+ weight NOUN O
2966
+ gain NOUN O
2967
+ velocity NOUN O
2968
+ after ADP O
2969
+ two NUM O
2970
+ weeks NOUN O
2971
+ , PUNCT O
2972
+ length NOUN B-LF
2973
+ of ADP I-LF
2974
+ stay NOUN I-LF
2975
+ ( PUNCT O
2976
+ LoS PROPN B-AC
2977
+ ) PUNCT O
2978
+ , PUNCT O
2979
+ discharge NOUN O
2980
+ anthropometrics NOUN O
2981
+ , PUNCT O
2982
+ linear ADJ O
2983
+ and CCONJ O
2984
+ MUAC PROPN B-AC
2985
+ growth NOUN O
2986
+ , PUNCT O
2987
+ treatment NOUN O
2988
+ outcome NOUN O
2989
+ , PUNCT O
2990
+ morbidity NOUN O
2991
+ , PUNCT O
2992
+ and CCONJ O
2993
+ relapses NOUN O
2994
+ . PUNCT O
2995
+
2996
+ PRISMA PROPN B-AC
2997
+ , PUNCT O
2998
+ Preferred ADJ B-LF
2999
+ Reporting NOUN I-LF
3000
+ Items NOUN I-LF
3001
+ for ADP I-LF
3002
+ Systematic ADJ I-LF
3003
+ Reviews NOUN I-LF
3004
+ and CCONJ I-LF
3005
+ Meta NOUN I-LF
3006
+ - NOUN I-LF
3007
+ Analyses NOUN I-LF
3008
+ . PUNCT O
3009
+
3010
+ Although SCONJ O
3011
+ the DET O
3012
+ phosphorylation NOUN O
3013
+ of ADP O
3014
+ eIF2α NOUN B-AC
3015
+ leads VERB O
3016
+ to ADP O
3017
+ attenuation NOUN O
3018
+ of ADP O
3019
+ the DET O
3020
+ translation NOUN O
3021
+ of ADP O
3022
+ most ADJ O
3023
+ transcripts NOUN O
3024
+ , PUNCT O
3025
+ it PRON O
3026
+ also ADV O
3027
+ increases VERB O
3028
+ the DET O
3029
+ translation NOUN O
3030
+ of ADP O
3031
+ specific ADJ O
3032
+ mRNAs NOUN O
3033
+ such ADJ O
3034
+ as ADP O
3035
+ activating VERB B-LF
3036
+ transcription NOUN I-LF
3037
+ factor NOUN I-LF
3038
+ 4 NUM I-LF
3039
+ ( PUNCT O
3040
+ ATF4 PROPN B-AC
3041
+ ) PUNCT O
3042
+ [ X O
3043
+ 41 NUM O
3044
+ ] X O
3045
+ as ADP O
3046
+ part NOUN O
3047
+ of ADP O
3048
+ the DET O
3049
+ stress NOUN O
3050
+ response NOUN O
3051
+ . PUNCT O
3052
+
3053
+ Bradykinin NOUN B-LF
3054
+ ( PUNCT O
3055
+ BK)-related PROPN B-AC
3056
+ peptides NOUN O
3057
+ , PUNCT O
3058
+ derived VERB O
3059
+ from ADP O
3060
+ the DET O
3061
+ selective ADJ O
3062
+ cleavage NOUN O
3063
+ of ADP O
3064
+ circulating VERB O
3065
+ kininogens NOUN O
3066
+ , PUNCT O
3067
+ stimulate VERB O
3068
+ two NUM O
3069
+ related ADJ O
3070
+ G PROPN O
3071
+ protein NOUN O
3072
+ coupled VERB O
3073
+ receptors NOUN O
3074
+ : PUNCT O
3075
+ the DET O
3076
+ widely ADV O
3077
+ expressed VERB O
3078
+ BK PROPN B-AC
3079
+ B2 PROPN B-LF
3080
+ receptor NOUN I-LF
3081
+ ( PUNCT O
3082
+ B2R NOUN B-AC
3083
+ ) PUNCT O
3084
+ and CCONJ O
3085
+ the DET O
3086
+ strongly ADV O
3087
+ regulated VERB O
3088
+ B1 PROPN B-LF
3089
+ receptor NOUN I-LF
3090
+ ( PUNCT O
3091
+ B1R NOUN B-AC
3092
+ ) PUNCT O
3093
+ [ PUNCT O
3094
+ 1 NUM O
3095
+ ] PUNCT O
3096
+ . PUNCT O
3097
+
3098
+ • PUNCT O
3099
+ LC PROPN B-AC
3100
+ is AUX O
3101
+ not PART O
3102
+ a DET O
3103
+ common ADJ O
3104
+ abbreviation NOUN O
3105
+ ; PUNCT O
3106
+ I PRON O
3107
+ suggest VERB O
3108
+ to PART O
3109
+ write VERB O
3110
+ liver NOUN B-LF
3111
+ cirrhosis NOUN I-LF
3112
+ in ADP O
3113
+ full ADJ O
3114
+ throughout ADP O
3115
+ . PUNCT O
3116
+
3117
+ AAA PROPN B-AC
3118
+ , PUNCT O
3119
+ abdominal ADJ B-LF
3120
+ aortic ADJ I-LF
3121
+ aneurysm NOUN I-LF
3122
+ ; PUNCT O
3123
+ Ang PROPN B-AC
3124
+ II NUM B-AC
3125
+ , PUNCT O
3126
+ angiotensin NOUN B-LF
3127
+ II NUM I-LF
3128
+ ; PUNCT O
3129
+ Drp1 PROPN B-AC
3130
+ , PUNCT O
3131
+ dynamin NOUN B-LF
3132
+ - PUNCT I-LF
3133
+ related VERB I-LF
3134
+ protein NOUN I-LF
3135
+ 1 NUM I-LF
3136
+ ; PUNCT O
3137
+ Mdivi-1 PROPN B-AC
3138
+ , PUNCT O
3139
+ mitochondrial ADJ B-LF
3140
+ division NOUN I-LF
3141
+ inhibitor NOUN I-LF
3142
+ 1 NUM I-LF
3143
+ ; PUNCT O
3144
+ Mfn1 PROPN B-AC
3145
+ , PUNCT O
3146
+ mitofusin NOUN B-LF
3147
+ 1 NUM I-LF
3148
+ ; PUNCT O
3149
+ MTG PROPN B-AC
3150
+ , PUNCT O
3151
+ MitoTracker PROPN B-LF
3152
+ Green PROPN I-LF
3153
+ ; PUNCT O
3154
+ mtROS PROPN B-AC
3155
+ , PUNCT O
3156
+ mitochondrial ADJ B-LF
3157
+ ROS NOUN I-LF
3158
+ ; PUNCT O
3159
+ si PROPN O
3160
+ - PUNCT O
3161
+ Drp1 PROPN B-AC
3162
+ , PUNCT O
3163
+ short ADJ O
3164
+ interfering VERB O
3165
+ RNA NOUN O
3166
+ targeting VERB O
3167
+ Drp1 PROPN B-AC
3168
+ ; PUNCT O
3169
+ si PROPN O
3170
+ - PUNCT O
3171
+ NC PROPN O
3172
+ , PUNCT O
3173
+ short ADJ O
3174
+ interfering VERB O
3175
+ RNA NOUN O
3176
+ control NOUN O
3177
+ ; PUNCT O
3178
+ VSMC PROPN B-AC
3179
+ , PUNCT O
3180
+ vascular ADJ B-LF
3181
+ smooth ADJ I-LF
3182
+ muscle NOUN I-LF
3183
+ cell NOUN I-LF
3184
+ . PUNCT O
3185
+
3186
+ Stimulus NOUN B-LF
3187
+ - PUNCT I-LF
3188
+ specific ADJ I-LF
3189
+ adaptation NOUN I-LF
3190
+ ( PUNCT O
3191
+ SSA PROPN B-AC
3192
+ ) PUNCT O
3193
+ in ADP O
3194
+ single ADJ O
3195
+ neurons NOUN O
3196
+ of ADP O
3197
+ the DET O
3198
+ auditory ADJ O
3199
+ cortex NOUN O
3200
+ was AUX O
3201
+ suggested VERB O
3202
+ to PART O
3203
+ be AUX O
3204
+ a DET O
3205
+ potential ADJ O
3206
+ neural ADJ O
3207
+ correlate NOUN O
3208
+ of ADP O
3209
+ the DET O
3210
+ mismatch NOUN B-LF
3211
+ negativity NOUN I-LF
3212
+ ( PUNCT O
3213
+ MMN PROPN B-AC
3214
+ ) PUNCT O
3215
+ , PUNCT O
3216
+ a DET O
3217
+ widely ADV O
3218
+ studied ADJ O
3219
+ component NOUN O
3220
+ of ADP O
3221
+ the DET O
3222
+ auditory ADJ O
3223
+ event NOUN B-LF
3224
+ - PUNCT I-LF
3225
+ related VERB I-LF
3226
+ potentials NOUN I-LF
3227
+ ( PUNCT O
3228
+ ERP PROPN B-AC
3229
+ ) PUNCT O
3230
+ that PRON O
3231
+ is AUX O
3232
+ elicited VERB O
3233
+ by ADP O
3234
+ changes NOUN O
3235
+ in ADP O
3236
+ the DET O
3237
+ auditory ADJ O
3238
+ environment NOUN O
3239
+ . PUNCT O
3240
+
3241
+ One NUM O
3242
+ identified VERB O
3243
+ candidate NOUN O
3244
+ for ADP O
3245
+ asparagine NOUN O
3246
+ hydroxylation NOUN O
3247
+ was AUX O
3248
+ the DET O
3249
+ deubiquitinase NOUN B-LF
3250
+ ( PUNCT O
3251
+ DUB PROPN B-AC
3252
+ ) PUNCT O
3253
+ ovarian ADJ B-LF
3254
+ tumor NOUN I-LF
3255
+ domain NOUN I-LF
3256
+ containing VERB I-LF
3257
+ ubiquitin NOUN I-LF
3258
+ aldehyde NOUN I-LF
3259
+ binding VERB I-LF
3260
+ protein NOUN I-LF
3261
+ 1 NUM I-LF
3262
+ ( PUNCT O
3263
+ OTUB1 PROPN B-AC
3264
+ ) PUNCT O
3265
+ ( PUNCT O
3266
+ Uniprot PROPN O
3267
+ accession NOUN O
3268
+ number NOUN O
3269
+ : PUNCT O
3270
+ Q96FW1 PROPN O
3271
+ ) PUNCT O
3272
+ [ PUNCT O
3273
+ 19 NUM O
3274
+ ] PUNCT O
3275
+ . PUNCT O
3276
+
3277
+ These DET O
3278
+ visits NOUN O
3279
+ are AUX O
3280
+ augmented VERB O
3281
+ by ADP O
3282
+ visits NOUN O
3283
+ from ADP O
3284
+ the DET O
3285
+ volunteer NOUN O
3286
+ community NOUN O
3287
+ health NOUN O
3288
+ workers NOUN O
3289
+ ( PUNCT O
3290
+ Shasthya PROPN B-LF
3291
+ Shebika PROPN I-LF
3292
+ [ PUNCT O
3293
+ SSs PROPN B-AC
3294
+ ] PUNCT O
3295
+ ) PUNCT O
3296
+ , PUNCT O
3297
+ a DET O
3298
+ cadre NOUN O
3299
+ chosen VERB O
3300
+ from ADP O
3301
+ and CCONJ O
3302
+ by ADP O
3303
+ their PRON O
3304
+ communities NOUN O
3305
+ who PRON O
3306
+ receive VERB O
3307
+ a DET O
3308
+ 15 NUM O
3309
+ - PUNCT O
3310
+ day NOUN O
3311
+ training NOUN O
3312
+ course NOUN O
3313
+ followed VERB O
3314
+ by ADP O
3315
+ monthly ADJ O
3316
+ refresher NOUN O
3317
+ training NOUN O
3318
+ and CCONJ O
3319
+ ad X O
3320
+ hoc X O
3321
+ 3 NUM O
3322
+ - PUNCT O
3323
+ day NOUN O
3324
+ intensive ADJ O
3325
+ training NOUN O
3326
+ for ADP O
3327
+ new ADJ O
3328
+ content NOUN O
3329
+ areas NOUN O
3330
+ . PUNCT O
3331
+
3332
+ CI PROPN B-AC
3333
+ , PUNCT O
3334
+ confidence NOUN B-LF
3335
+ interval NOUN I-LF
3336
+ ; PUNCT O
3337
+ DNI PROPN B-AC
3338
+ , PUNCT O
3339
+ delta NOUN B-LF
3340
+ neutrophil NOUN I-LF
3341
+ index NOUN I-LF
3342
+ ; PUNCT O
3343
+ SOFA PROPN B-AC
3344
+ , PUNCT O
3345
+ sequential ADJ B-LF
3346
+ organ NOUN I-LF
3347
+ failure NOUN I-LF
3348
+ assessment NOUN I-LF
3349
+ ; PUNCT O
3350
+ POD1 PROPN O
3351
+ , PUNCT O
3352
+ postoperative ADJ O
3353
+ day NOUN O
3354
+ 1 NUM O
3355
+ ; PUNCT O
3356
+ ICU PROPN B-AC
3357
+ , PUNCT O
3358
+ intensive ADJ B-LF
3359
+ care NOUN I-LF
3360
+ unit NOUN I-LF
3361
+ . PUNCT O
3362
+
3363
+ It PRON O
3364
+ was AUX O
3365
+ shown VERB O
3366
+ previously ADV O
3367
+ that SCONJ O
3368
+ antiviral ADJ O
3369
+ RNAi NOUN B-AC
3370
+ in ADP O
3371
+ honey NOUN O
3372
+ bees NOUN O
3373
+ could AUX O
3374
+ be AUX O
3375
+ induced VERB O
3376
+ by ADP O
3377
+ introduction NOUN O
3378
+ of ADP O
3379
+ double ADJ B-LF
3380
+ - PUNCT I-LF
3381
+ stranded ADJ I-LF
3382
+ RNA NOUN I-LF
3383
+ ( PUNCT O
3384
+ dsRNA NOUN B-AC
3385
+ ) PUNCT O
3386
+ molecules NOUN O
3387
+ orally ADV O
3388
+ [ X O
3389
+ 30 NUM O
3390
+ ] PUNCT O
3391
+ . PUNCT O
3392
+
3393
+ In ADP O
3394
+ the DET O
3395
+ Leiden PROPN B-LF
3396
+ Thrombophilia PROPN I-LF
3397
+ Study PROPN I-LF
3398
+ ( PUNCT O
3399
+ LETS PROPN B-AC
3400
+ ) PUNCT O
3401
+ , PUNCT O
3402
+ both CCONJ O
3403
+ cytokines NOUN O
3404
+ and CCONJ O
3405
+ tumour NOUN B-LF
3406
+ necrosis NOUN I-LF
3407
+ factor NOUN I-LF
3408
+ alpha NOUN I-LF
3409
+ ( PUNCT O
3410
+ TNF PROPN B-AC
3411
+ - ADJ B-AC
3412
+ α NOUN B-AC
3413
+ ) PUNCT O
3414
+ were AUX O
3415
+ associated VERB O
3416
+ with ADP O
3417
+ a DET O
3418
+ 2- NUM O
3419
+ to PART O
3420
+ 3 NUM O
3421
+ - ADJ O
3422
+ fold ADJ O
3423
+ increased VERB O
3424
+ risk NOUN O
3425
+ of ADP O
3426
+ a DET O
3427
+ first ADJ O
3428
+ VT PROPN B-AC
3429
+ , PUNCT O
3430
+ whereas SCONJ O
3431
+ the DET O
3432
+ risk NOUN O
3433
+ for ADP O
3434
+ IL-10 NOUN B-AC
3435
+ seemed VERB O
3436
+ to PART O
3437
+ be AUX O
3438
+ decreased VERB O
3439
+ [ PUNCT O
3440
+ 17 NUM O
3441
+ ] PUNCT O
3442
+ . PUNCT O
3443
+
3444
+ In ADP O
3445
+ 93/255 NUM O
3446
+ ( PUNCT O
3447
+ 36 NUM O
3448
+ % NOUN O
3449
+ ) PUNCT O
3450
+ non ADJ O
3451
+ - ADJ O
3452
+ Cochrane PROPN O
3453
+ SRs NOUN B-AC
3454
+ , PUNCT O
3455
+ authors NOUN O
3456
+ reported VERB O
3457
+ using VERB O
3458
+ Cochrane PROPN O
3459
+ methods NOUN O
3460
+ ( PUNCT O
3461
+ e.g. X O
3462
+ , PUNCT O
3463
+ cited VERB O
3464
+ the DET O
3465
+ Cochrane PROPN O
3466
+ Handbook PROPN O
3467
+ for ADP O
3468
+ Systematic PROPN B-LF
3469
+ Reviews PROPN I-LF
3470
+ of ADP O
3471
+ Interventions PROPN O
3472
+ [ PUNCT O
3473
+ 19 NUM O
3474
+ ] PUNCT O
3475
+ ) PUNCT O
3476
+ . PUNCT O
3477
+
3478
+ PDB PROPN B-AC
3479
+ , PUNCT O
3480
+ Protein PROPN B-LF
3481
+ Data PROPN I-LF
3482
+ Bank PROPN I-LF
3483
+ ; PUNCT O
3484
+ RSVF PROPN B-AC
3485
+ , PUNCT O
3486
+ respiratory ADJ O
3487
+ syncytial ADJ O
3488
+ virus NOUN O
3489
+ fusion NOUN O
3490
+ protein NOUN O
3491
+ ; PUNCT O
3492
+ SASA PROPN O
3493
+ , PUNCT O
3494
+ solvent NOUN O
3495
+ accessible ADJ O
3496
+ surface NOUN O
3497
+ area NOUN O
3498
+ . PUNCT O
3499
+
3500
+ CBA PROPN O
3501
+ : PUNCT O
3502
+ cytometric ADJ O
3503
+ bead NOUN O
3504
+ array NOUN O
3505
+ ; PUNCT O
3506
+ CDS PROPN B-AC
3507
+ : PUNCT O
3508
+ clinical ADJ B-LF
3509
+ disease NOUN I-LF
3510
+ score NOUN I-LF
3511
+ ; PUNCT O
3512
+ CLP PROPN B-AC
3513
+ : PUNCT O
3514
+ caecal NOUN B-LF
3515
+ ligation NOUN I-LF
3516
+ and CCONJ I-LF
3517
+ puncture NOUN I-LF
3518
+ ; PUNCT O
3519
+ MLN NOUN B-AC
3520
+ : PUNCT O
3521
+ mesenteric ADJ B-LF
3522
+ lymph NOUN I-LF
3523
+ nodes NOUN I-LF
3524
+ ; PUNCT O
3525
+ mRNA NOUN O
3526
+ : PUNCT O
3527
+ messenger NOUN O
3528
+ ribonucleic NOUN O
3529
+ acid NOUN O
3530
+ ; PUNCT O
3531
+ RT NOUN O
3532
+ - PUNCT O
3533
+ PCR PROPN O
3534
+ : PUNCT O
3535
+ reverse ADJ O
3536
+ transcriptase NOUN O
3537
+ real ADJ O
3538
+ - PUNCT O
3539
+ time NOUN O
3540
+ polymerase NOUN O
3541
+ chain NOUN O
3542
+ reaction NOUN O
3543
+ . PUNCT O
3544
+
3545
+ Recently ADV O
3546
+ , PUNCT O
3547
+ the DET O
3548
+ gene NOUN O
3549
+ family NOUN O
3550
+ arylamine NOUN B-LF
3551
+ N NOUN I-LF
3552
+ - NOUN I-LF
3553
+ acetyltransferases NOUN I-LF
3554
+ ( PUNCT O
3555
+ NATs NOUN B-AC
3556
+ ) PUNCT O
3557
+ , PUNCT O
3558
+ which PRON O
3559
+ is AUX O
3560
+ another DET O
3561
+ phase NOUN O
3562
+ II NUM O
3563
+ enzyme NOUN O
3564
+ has AUX O
3565
+ been AUX O
3566
+ shown VERB O
3567
+ to PART O
3568
+ be AUX O
3569
+ phylogenetically ADV O
3570
+ unstable ADJ O
3571
+ too ADV O
3572
+ [ PUNCT O
3573
+ 7 NUM O
3574
+ ] PUNCT O
3575
+ . PUNCT O
3576
+
3577
+ microRNAs NOUN B-LF
3578
+ ( PUNCT O
3579
+ miRNAs NOUN B-AC
3580
+ ) PUNCT O
3581
+ are AUX O
3582
+ important ADJ O
3583
+ post ADJ O
3584
+ - ADJ O
3585
+ transcriptional ADJ O
3586
+ regulators NOUN O
3587
+ , PUNCT O
3588
+ but CCONJ O
3589
+ the DET O
3590
+ extent NOUN O
3591
+ of ADP O
3592
+ this DET O
3593
+ regulation NOUN O
3594
+ is AUX O
3595
+ uncertain ADJ O
3596
+ , PUNCT O
3597
+ both PRON O
3598
+ with ADP O
3599
+ regard NOUN O
3600
+ to ADP O
3601
+ the DET O
3602
+ number NOUN O
3603
+ of ADP O
3604
+ miRNA NOUN B-AC
3605
+ genes NOUN O
3606
+ and CCONJ O
3607
+ their PRON O
3608
+ targets NOUN O
3609
+ . PUNCT O
3610
+
3611
+ Top NOUN B-LF
3612
+ of ADP I-LF
3613
+ SF NOUN I-LF
3614
+ or CCONJ I-LF
3615
+ AS NOUN I-LF
3616
+
3617
+ To ADP O
3618
+ our PRON O
3619
+ knowledge NOUN O
3620
+ , PUNCT O
3621
+ this PRON O
3622
+ is AUX O
3623
+ the DET O
3624
+ most ADV O
3625
+ diversified ADJ O
3626
+ and CCONJ O
3627
+ comprehensive ADJ O
3628
+ panel NOUN O
3629
+ of ADP O
3630
+ clinical ADJ O
3631
+ and CCONJ O
3632
+ genotype NOUN O
3633
+ specimens NOUN O
3634
+ used VERB O
3635
+ in ADP O
3636
+ HCV NOUN B-AC
3637
+ nucleic NOUN B-LF
3638
+ acid NOUN I-LF
3639
+ testing NOUN I-LF
3640
+ ( PUNCT O
3641
+ NAT PROPN B-AC
3642
+ ) PUNCT O
3643
+ validation NOUN O
3644
+ to ADP O
3645
+ date NOUN O
3646
+ . PUNCT O
3647
+
3648
+ Parents NOUN O
3649
+ completed VERB O
3650
+ the DET O
3651
+ Behavior PROPN B-LF
3652
+ Assessment PROPN I-LF
3653
+ System PROPN I-LF
3654
+ for ADP I-LF
3655
+ Children PROPN I-LF
3656
+ , PUNCT I-LF
3657
+ Second PROPN I-LF
3658
+ Edition PROPN I-LF
3659
+ ( PUNCT O
3660
+ BASC-2 PROPN B-AC
3661
+ ) PUNCT O
3662
+ [ PUNCT O
3663
+ 27 NUM O
3664
+ ] PUNCT O
3665
+ , PUNCT O
3666
+ and CCONJ O
3667
+ the DET O
3668
+ Behavior PROPN B-LF
3669
+ Rating PROPN I-LF
3670
+ Inventory PROPN I-LF
3671
+ of ADP I-LF
3672
+ Executive PROPN I-LF
3673
+ Function PROPN I-LF
3674
+ ( PUNCT O
3675
+ BRIEF PROPN B-AC
3676
+ ) PUNCT O
3677
+ [ PUNCT O
3678
+ 28 NUM O
3679
+ ] PUNCT O
3680
+ . PUNCT O
3681
+
3682
+ Interestingly ADV O
3683
+ , PUNCT O
3684
+ one NUM O
3685
+ group NOUN O
3686
+ reported VERB O
3687
+ that SCONJ O
3688
+ the DET O
3689
+ prostate NOUN B-LF
3690
+ apoptosis NOUN I-LF
3691
+ response NOUN I-LF
3692
+ 4 NUM I-LF
3693
+ ( PUNCT O
3694
+ PAR-4 NOUN B-AC
3695
+ ) PUNCT O
3696
+ , PUNCT O
3697
+ a DET O
3698
+ substrate NOUN O
3699
+ of ADP O
3700
+ ZIPK PROPN B-AC
3701
+ , PUNCT O
3702
+ is AUX O
3703
+ capable ADJ O
3704
+ of ADP O
3705
+ translocating VERB O
3706
+ ZIPK PROPN B-AC
3707
+ from ADP O
3708
+ the DET O
3709
+ PODs NOUN B-AC
3710
+ to ADP O
3711
+ the DET O
3712
+ actin NOUN O
3713
+ microfilaments NOUN O
3714
+ [ X O
3715
+ 4,12,13 NUM O
3716
+ ] PUNCT O
3717
+ . PUNCT O
3718
+
3719
+ BFP PROPN B-AC
3720
+ , PUNCT O
3721
+ body NOUN B-LF
3722
+ fat NOUN I-LF
3723
+ percentage NOUN I-LF
3724
+ ; PUNCT O
3725
+ CE PROPN B-AC
3726
+ , PUNCT O
3727
+ cholesteryl NOUN B-LF
3728
+ ester NOUN I-LF
3729
+ ; PUNCT O
3730
+ Chol PROPN B-AC
3731
+ , PUNCT O
3732
+ cholesterol NOUN B-LF
3733
+ ; PUNCT O
3734
+ DAG PROPN B-AC
3735
+ , PUNCT O
3736
+ diacylglyceride NOUN B-LF
3737
+ ; PUNCT O
3738
+ LPC PROPN B-AC
3739
+ , PUNCT O
3740
+ lysophosphatidylcholine NOUN B-LF
3741
+ ; PUNCT O
3742
+ MAE PROPN B-AC
3743
+ , PUNCT O
3744
+ mean ADJ B-LF
3745
+ absolute ADJ I-LF
3746
+ error NOUN I-LF
3747
+ ; PUNCT O
3748
+ PC PROPN B-AC
3749
+ , PUNCT O
3750
+ phosphatidylcholine NOUN B-LF
3751
+ ; PUNCT O
3752
+ PE PROPN B-AC
3753
+ , PUNCT O
3754
+ phosphatidylethanolamine NOUN B-LF
3755
+ ; PUNCT O
3756
+ PI PROPN O
3757
+ , PUNCT O
3758
+ phosphatidylinositol NOUN O
3759
+ ; PUNCT O
3760
+ SM PROPN B-AC
3761
+ , PUNCT O
3762
+ sphingomyelin NOUN B-LF
3763
+ ; PUNCT O
3764
+ TAG PROPN B-AC
3765
+ , PUNCT O
3766
+ triacylglyceride NOUN B-LF
3767
+ . PUNCT O
3768
+
3769
+ Expression NOUN O
3770
+ levels NOUN O
3771
+ of ADP O
3772
+ frizzled ADJ O
3773
+ homolog NOUN O
3774
+ 9 NUM O
3775
+ ( PUNCT O
3776
+ Fzd9 PROPN O
3777
+ ) PUNCT O
3778
+ , PUNCT O
3779
+ calsequestrin NOUN B-LF
3780
+ 2 NUM I-LF
3781
+ ( PUNCT O
3782
+ Casq2 PROPN B-AC
3783
+ ) PUNCT O
3784
+ , PUNCT O
3785
+ potassium NOUN O
3786
+ large ADJ O
3787
+ conductance NOUN O
3788
+ calcium NOUN O
3789
+ - PUNCT O
3790
+ activated VERB O
3791
+ channel NOUN O
3792
+ , PUNCT O
3793
+ subfamily NOUN O
3794
+ M PROPN O
3795
+ , PUNCT O
3796
+ alpha NOUN O
3797
+ member NOUN O
3798
+ 1 NUM O
3799
+ ( PUNCT O
3800
+ Kcnma1 PROPN O
3801
+ ) PUNCT O
3802
+ , PUNCT O
3803
+ peroxisome NOUN O
3804
+ proliferator NOUN O
3805
+ activated VERB O
3806
+ receptor NOUN O
3807
+ alpha NOUN O
3808
+ ( PUNCT O
3809
+ Ppara PROPN O
3810
+ ) PUNCT O
3811
+ , PUNCT O
3812
+ actinin NOUN O
3813
+ alpha NOUN O
3814
+ 3 NUM O
3815
+ ( PUNCT O
3816
+ Actn3 PROPN O
3817
+ ) PUNCT O
3818
+ , PUNCT O
3819
+ myogenic NOUN O
3820
+ factor NOUN O
3821
+ 6 NUM O
3822
+ ( PUNCT O
3823
+ Myf6 PROPN O
3824
+ ) PUNCT O
3825
+ , PUNCT O
3826
+ myostatin NOUN O
3827
+ ( PUNCT O
3828
+ Mstn PROPN O
3829
+ ) PUNCT O
3830
+ and CCONJ O
3831
+ Muscle PROPN O
3832
+ RING PROPN O
3833
+ Finger PROPN O
3834
+ 1 NUM O
3835
+ ( PUNCT O
3836
+ MuRF1 PROPN O
3837
+ ) PUNCT O
3838
+ were AUX O
3839
+ evaluated VERB O
3840
+ by ADP O
3841
+ real ADJ O
3842
+ - PUNCT O
3843
+ time NOUN O
3844
+ quantitative ADJ O
3845
+ PCR NOUN O
3846
+ in ADP O
3847
+ soleus NOUN O
3848
+ of ADP O
3849
+ flown VERB O
3850
+ ( PUNCT O
3851
+ BF PROPN B-AC
3852
+ ) PUNCT O
3853
+ and CCONJ O
3854
+ ground NOUN O
3855
+ control NOUN O
3856
+ mice NOUN O
3857
+ ( PUNCT O
3858
+ BG PROPN B-AC
3859
+ ) PUNCT O
3860
+ . PUNCT O
3861
+ Actb PROPN O
3862
+ ( PUNCT O
3863
+ beta NOUN O
3864
+ actin NOUN O
3865
+ ) PUNCT O
3866
+ was AUX O
3867
+ used VERB O
3868
+ as ADP O
3869
+ housekeeping NOUN O
3870
+ to PART O
3871
+ calculate VERB O
3872
+ the DET O
3873
+ delta NOUN O
3874
+ Ct NOUN O
3875
+ of ADP O
3876
+ the DET O
3877
+ selected VERB O
3878
+ genes NOUN O
3879
+ . PUNCT O
3880
+
3881
+ BCI PROPN B-AC
3882
+ , PUNCT O
3883
+ brain NOUN B-LF
3884
+ – PUNCT I-LF
3885
+ computer NOUN I-LF
3886
+ interface NOUN I-LF
3887
+ . PUNCT O
3888
+
3889
+ During ADP O
3890
+ stimulus NOUN O
3891
+ presentation NOUN O
3892
+ , PUNCT O
3893
+ one NUM O
3894
+ of ADP O
3895
+ the DET O
3896
+ following ADJ O
3897
+ gestures NOUN O
3898
+ was AUX O
3899
+ performed VERB O
3900
+ by ADP O
3901
+ the DET O
3902
+ experimenter NOUN O
3903
+ : PUNCT O
3904
+ TP NOUN B-AC
3905
+ , PUNCT O
3906
+ MO NOUN B-AC
3907
+ , PUNCT O
3908
+ LPS NOUN B-AC
3909
+ , PUNCT O
3910
+ HO NOUN B-AC
3911
+ , PUNCT O
3912
+ or CCONJ O
3913
+ eyes NOUN B-LF
3914
+ opening NOUN I-LF
3915
+ ( PUNCT O
3916
+ EYE NOUN B-AC
3917
+ , PUNCT O
3918
+ biological ADJ O
3919
+ control NOUN O
3920
+ condition NOUN O
3921
+ ) PUNCT O
3922
+ . PUNCT O
3923
+
3924
+ The DET O
3925
+ study NOUN O
3926
+ pharmacist NOUN O
3927
+ reviewed VERB O
3928
+ drug NOUN B-LF
3929
+ - PUNCT I-LF
3930
+ drug NOUN I-LF
3931
+ interactions NOUN I-LF
3932
+ ( PUNCT O
3933
+ DDIs NOUN B-AC
3934
+ ) PUNCT O
3935
+ , PUNCT O
3936
+ DGIs NOUN B-AC
3937
+ , PUNCT O
3938
+ and CCONJ O
3939
+ cumulative ADJ O
3940
+ drug NOUN O
3941
+ and/or CCONJ O
3942
+ gene NOUN O
3943
+ interactions NOUN O
3944
+ in ADP O
3945
+ the DET O
3946
+ tested VERB O
3947
+ group NOUN O
3948
+ using VERB O
3949
+ the DET O
3950
+ YouScript PROPN O
3951
+ ® NUM O
3952
+ generated VERB O
3953
+ reports NOUN O
3954
+ and CCONJ O
3955
+ CDST NOUN B-AC
3956
+ to ADP O
3957
+ provide VERB O
3958
+ drug NOUN O
3959
+ therapy NOUN O
3960
+ recommendations NOUN O
3961
+ to ADP O
3962
+ clinicians NOUN O
3963
+ , PUNCT O
3964
+ after ADP O
3965
+ which PRON O
3966
+ prescriptions NOUN O
3967
+ were AUX O
3968
+ altered VERB O
3969
+ at ADP O
3970
+ clinician NOUN O
3971
+ discretion NOUN O
3972
+ . PUNCT O
3973
+
3974
+ This DET O
3975
+ discovery NOUN O
3976
+ dataset NOUN O
3977
+ was AUX O
3978
+ collected VERB O
3979
+ by ADP O
3980
+ a DET O
3981
+ Japanese ADJ O
3982
+ nationwide ADJ O
3983
+ database NOUN O
3984
+ project NOUN O
3985
+ called VERB O
3986
+ the DET O
3987
+ Strategic PROPN B-LF
3988
+ Research PROPN I-LF
3989
+ Program PROPN I-LF
3990
+ for ADP I-LF
3991
+ Brain PROPN I-LF
3992
+ Science PROPN I-LF
3993
+ ( PUNCT O
3994
+ SRPBS PROPN B-AC
3995
+ , PUNCT O
3996
+ https://bicr.atr.jp/decnefpro/ X O
3997
+ ) PUNCT O
3998
+ since SCONJ O
3999
+ 2014 NUM O
4000
+ . PUNCT O
4001
+
4002
+ The DET O
4003
+ ability NOUN O
4004
+ of ADP O
4005
+ glycine NOUN O
4006
+ to PART O
4007
+ hyperpolarize VERB O
4008
+ cells NOUN O
4009
+ depends VERB O
4010
+ on ADP O
4011
+ the DET O
4012
+ co NOUN O
4013
+ - NOUN O
4014
+ expression NOUN O
4015
+ of ADP O
4016
+ the DET O
4017
+ ion NOUN O
4018
+ channel NOUN O
4019
+ solute NOUN B-LF
4020
+ carrier NOUN I-LF
4021
+ family NOUN I-LF
4022
+ 12 NUM I-LF
4023
+ ( PUNCT I-LF
4024
+ potassium NOUN I-LF
4025
+ / SYM I-LF
4026
+ chloride NOUN I-LF
4027
+ transporter NOUN I-LF
4028
+ ) PUNCT I-LF
4029
+ , PUNCT I-LF
4030
+ member NOUN I-LF
4031
+ 5b NOUN I-LF
4032
+ ( PUNCT O
4033
+ KCC2 NOUN B-AC
4034
+ ) PUNCT O
4035
+ and CCONJ O
4036
+ the DET O
4037
+ glycine NOUN O
4038
+ receptor NOUN O
4039
+ . PUNCT O
4040
+
4041
+ Two NUM O
4042
+ randomised ADJ B-LF
4043
+ controlled VERB I-LF
4044
+ trials NOUN I-LF
4045
+ ( PUNCT O
4046
+ RCTs NOUN B-AC
4047
+ ) PUNCT O
4048
+ recently ADV O
4049
+ evaluated VERB O
4050
+ the DET O
4051
+ risk NOUN O
4052
+ of ADP O
4053
+ adverse ADJ O
4054
+ perinatal ADJ O
4055
+ outcome NOUN O
4056
+ after ADP O
4057
+ a DET O
4058
+ policy NOUN O
4059
+ of ADP O
4060
+ induction NOUN B-LF
4061
+ of ADP I-LF
4062
+ labour NOUN I-LF
4063
+ ( PUNCT O
4064
+ IOL PROPN B-AC
4065
+ ) PUNCT O
4066
+ at ADP O
4067
+ 41 NUM O
4068
+ weeks NOUN O
4069
+ as SCONJ O
4070
+ compared VERB O
4071
+ with ADP O
4072
+ expectant ADJ O
4073
+ management NOUN O
4074
+ until ADP O
4075
+ 42 NUM O
4076
+ weeks NOUN O
4077
+ [ PUNCT O
4078
+ 6,7 NUM O
4079
+ ] PUNCT O
4080
+ . PUNCT O
4081
+
4082
+ HR NOUN O
4083
+ , PUNCT O
4084
+ hazard NOUN O
4085
+ ratio NOUN O
4086
+ ; PUNCT O
4087
+ CI PROPN O
4088
+ , PUNCT O
4089
+ confidence NOUN O
4090
+ interval NOUN O
4091
+ ; PUNCT O
4092
+ ECOG PROPN B-AC
4093
+ , PUNCT O
4094
+ Eastern PROPN B-LF
4095
+ Cooperative PROPN I-LF
4096
+ Oncology PROPN I-LF
4097
+ Group PROPN I-LF
4098
+ ; PUNCT O
4099
+ DM NOUN O
4100
+ , PUNCT O
4101
+ diabetes NOUN O
4102
+ mellitus NOUN O
4103
+ ; PUNCT O
4104
+ HTN PROPN O
4105
+ , PUNCT O
4106
+ hypertension NOUN O
4107
+ . PUNCT O
4108
+
4109
+ The DET O
4110
+ transition NOUN O
4111
+ from ADP O
4112
+ ln(1 NOUN O
4113
+ ) PUNCT O
4114
+ to ADP O
4115
+ ln(2.62 NOUN O
4116
+ ) PUNCT O
4117
+ over ADP O
4118
+ 130 NUM O
4119
+ million NUM B-LF
4120
+ years NOUN I-LF
4121
+ implies VERB O
4122
+ a DET O
4123
+ Paleozoic ADJ O
4124
+ long ADJ O
4125
+ - ADJ O
4126
+ term NOUN O
4127
+ net ADJ O
4128
+ diversification NOUN O
4129
+ rate NOUN O
4130
+ of ADP O
4131
+ 0.0202 NUM O
4132
+ ln(species)/Myr NOUN B-AC
4133
+ , PUNCT O
4134
+ which PRON O
4135
+ would AUX O
4136
+ generate VERB O
4137
+ more ADJ O
4138
+ than ADP O
4139
+ a DET O
4140
+ 40 ADJ O
4141
+ - ADJ O
4142
+ fold ADJ O
4143
+ increase NOUN O
4144
+ in ADP O
4145
+ diversity NOUN O
4146
+ over ADP O
4147
+ 190 NUM O
4148
+ Myr NOUN B-AC
4149
+ of ADP O
4150
+ Mesozoic ADJ O
4151
+ time NOUN O
4152
+ . PUNCT O
4153
+
4154
+ Acetaminophen NOUN B-LF
4155
+ ( PUNCT O
4156
+ APAP PROPN B-AC
4157
+ ) PUNCT O
4158
+ is AUX O
4159
+ a DET O
4160
+ commonly ADV O
4161
+ used VERB O
4162
+ analgesic NOUN O
4163
+ and CCONJ O
4164
+ antipyretic NOUN O
4165
+ that PRON O
4166
+ can AUX O
4167
+ cause VERB O
4168
+ hepatotoxicity NOUN O
4169
+ due ADP O
4170
+ to ADP O
4171
+ production NOUN O
4172
+ of ADP O
4173
+ toxic ADJ O
4174
+ metabolites NOUN O
4175
+ via ADP O
4176
+ cytochrome NOUN B-LF
4177
+ P450 PROPN I-LF
4178
+ ( PUNCT O
4179
+ Cyp PROPN B-AC
4180
+ ) PUNCT O
4181
+ 1a2 NUM O
4182
+ and CCONJ O
4183
+ Cyp2e1 PROPN O
4184
+ . PUNCT O
4185
+
4186
+ Publication NOUN O
4187
+ bias NOUN O
4188
+ was AUX O
4189
+ suspected VERB O
4190
+ in ADP O
4191
+ both CCONJ O
4192
+ the DET O
4193
+ PCS PROPN B-AC
4194
+ ( PUNCT O
4195
+ A NOUN O
4196
+ ) PUNCT O
4197
+ and CCONJ O
4198
+ MCS PROPN B-AC
4199
+ ( PUNCT O
4200
+ B NOUN O
4201
+ ) PUNCT O
4202
+ . PUNCT O
4203
+ MCS PROPN B-AC
4204
+ : PUNCT O
4205
+ mental ADJ B-LF
4206
+ component NOUN I-LF
4207
+ summary NOUN I-LF
4208
+ score NOUN I-LF
4209
+ ; PUNCT O
4210
+ PCS PROPN B-AC
4211
+ : PUNCT O
4212
+ physical ADJ B-LF
4213
+ component NOUN I-LF
4214
+ summary NOUN I-LF
4215
+ score NOUN I-LF
4216
+ ; PUNCT O
4217
+ RFCA PROPN B-AC
4218
+ : PUNCT O
4219
+ radiofrequency NOUN B-LF
4220
+ catheter NOUN I-LF
4221
+ ablation NOUN I-LF
4222
+ ; PUNCT O
4223
+ WMD PROPN B-AC
4224
+ : PUNCT O
4225
+ weighted VERB O
4226
+ mean ADJ O
4227
+ difference NOUN O
4228
+ . PUNCT O
4229
+
4230
+ In ADP O
4231
+ Saccharomyces PROPN O
4232
+ cerevisiae NOUN O
4233
+ , PUNCT O
4234
+ replication NOUN O
4235
+ origins NOUN O
4236
+ isolated VERB O
4237
+ in ADP O
4238
+ DNA PROPN O
4239
+ fragments NOUN O
4240
+ are AUX O
4241
+ known VERB O
4242
+ as ADP O
4243
+ autonomously ADV B-LF
4244
+ replicating VERB I-LF
4245
+ sequences NOUN I-LF
4246
+ ( PUNCT O
4247
+ ARSs PROPN B-AC
4248
+ ) PUNCT O
4249
+ . PUNCT O
4250
+
4251
+ The DET O
4252
+ additional ADJ O
4253
+ advantage NOUN O
4254
+ of ADP O
4255
+ NAATs PROPN B-AC
4256
+ is AUX O
4257
+ that SCONJ O
4258
+ they PRON O
4259
+ have VERB O
4260
+ a DET O
4261
+ real ADJ O
4262
+ - PUNCT O
4263
+ world NOUN O
4264
+ sensitivity NOUN O
4265
+ of ADP O
4266
+ 90%–96 NUM O
4267
+ % NOUN O
4268
+ , NOUN O
4269
+ which PRON O
4270
+ leads VERB O
4271
+ to ADP O
4272
+ a DET O
4273
+ lower ADJ O
4274
+ proportion NOUN O
4275
+ of ADP O
4276
+ untreated ADJ O
4277
+ infections NOUN O
4278
+ ( PUNCT O
4279
+ false ADJ O
4280
+ negative ADJ O
4281
+ tests NOUN O
4282
+ ) PUNCT O
4283
+ compared VERB O
4284
+ to ADP O
4285
+ antigen NOUN O
4286
+ - PUNCT O
4287
+ based VERB O
4288
+ methods NOUN O
4289
+ ( PUNCT O
4290
+ direct ADJ O
4291
+ immunofluorescence NOUN B-LF
4292
+ ( PUNCT O
4293
+ IF PROPN B-AC
4294
+ ) PUNCT O
4295
+ or CCONJ O
4296
+ direct ADJ B-LF
4297
+ fluorescent ADJ I-LF
4298
+ antibody NOUN I-LF
4299
+ ( PUNCT O
4300
+ DFA PROPN B-AC
4301
+ ) PUNCT O
4302
+ and CCONJ O
4303
+ enzyme NOUN O
4304
+ - PUNCT O
4305
+ linked VERB O
4306
+ immunosorbent NOUN O
4307
+ assay NOUN O
4308
+ ( PUNCT O
4309
+ ELISA PROPN B-AC
4310
+ ) PUNCT O
4311
+ or CCONJ O
4312
+ enzyme NOUN B-LF
4313
+ immunoassay NOUN I-LF
4314
+ ( PUNCT O
4315
+ EIA PROPN B-AC
4316
+ ) PUNCT O
4317
+ sensitivity NOUN O
4318
+ 65%–75 NUM O
4319
+ % NOUN O
4320
+ compared VERB O
4321
+ to ADP O
4322
+ NAAT PROPN B-AC
4323
+ ) PUNCT O
4324
+ [ PUNCT O
4325
+ 5,6 NUM O
4326
+ ] PUNCT O
4327
+ . PUNCT O
4328
+
4329
+ According VERB O
4330
+ to ADP O
4331
+ the DET O
4332
+ United PROPN B-LF
4333
+ Nations PROPN I-LF
4334
+ Children PROPN I-LF
4335
+ ’s PART I-LF
4336
+ Fund PROPN I-LF
4337
+ ( PUNCT O
4338
+ UNICEF PROPN B-AC
4339
+ ) PUNCT O
4340
+ , PUNCT O
4341
+ with ADP O
4342
+ respect NOUN O
4343
+ to ADP O
4344
+ breastfeeding NOUN O
4345
+ , PUNCT O
4346
+ every DET O
4347
+ second NOUN O
4348
+ counts VERB O
4349
+ in ADP O
4350
+ an DET O
4351
+ infant NOUN O
4352
+ ’s PART O
4353
+ life NOUN O
4354
+ . PUNCT O
4355
+
4356
+ We PRON O
4357
+ established VERB O
4358
+ a DET O
4359
+ working VERB O
4360
+ group NOUN O
4361
+ , PUNCT O
4362
+ the DET O
4363
+ Global PROPN B-LF
4364
+ Respiratory PROPN I-LF
4365
+ Hospitalizations PROPN I-LF
4366
+ – PUNCT I-LF
4367
+ Influenza PROPN I-LF
4368
+ Proportion PROPN I-LF
4369
+ Positive PROPN I-LF
4370
+ ( PUNCT O
4371
+ GRIPP PROPN B-AC
4372
+ ) PUNCT O
4373
+ Working PROPN O
4374
+ Group PROPN O
4375
+ . PUNCT O
4376
+
4377
+ Please AUX O
4378
+ note VERB O
4379
+ : PUNCT O
4380
+ fixed VERB O
4381
+ - PUNCT O
4382
+ dose NOUN O
4383
+ regimens NOUN O
4384
+ are AUX O
4385
+ in ADP O
4386
+ square ADJ O
4387
+ brackets NOUN O
4388
+ . PUNCT O
4389
+ 3TC PROPN O
4390
+ , PUNCT O
4391
+ lamivudine NOUN O
4392
+ ; PUNCT O
4393
+ ABC PROPN O
4394
+ , PUNCT O
4395
+ abacavir NOUN O
4396
+ ; PUNCT O
4397
+ d4 PROPN B-AC
4398
+ T PROPN B-AC
4399
+ , PUNCT O
4400
+ stavudine NOUN B-LF
4401
+ ; PUNCT O
4402
+ EFV PROPN B-AC
4403
+ , PUNCT O
4404
+ efavirenz NOUN B-LF
4405
+ ; PUNCT O
4406
+ FTC PROPN O
4407
+ , PUNCT O
4408
+ emtricitabine NOUN O
4409
+ ; PUNCT O
4410
+ LPV PROPN O
4411
+ / SYM O
4412
+ r NOUN O
4413
+ , PUNCT O
4414
+ lopinavir NOUN O
4415
+ / SYM O
4416
+ ritonavir NOUN O
4417
+ ; PUNCT O
4418
+ NVP PROPN B-AC
4419
+ , PUNCT O
4420
+ nevirapine NOUN B-LF
4421
+ ; PUNCT O
4422
+ TDF PROPN B-AC
4423
+ , PUNCT O
4424
+ tenofovir NOUN B-LF
4425
+ ; PUNCT O
4426
+ ZDV PROPN B-AC
4427
+ , PUNCT O
4428
+ zidovudine NOUN B-LF
4429
+ . PUNCT O
4430
+
4431
+ To PART O
4432
+ account VERB O
4433
+ for ADP O
4434
+ the DET O
4435
+ phenotypic ADJ O
4436
+ drug NOUN O
4437
+ tolerance NOUN O
4438
+ of ADP O
4439
+ Mycobacterium NOUN O
4440
+ tuberculosis NOUN O
4441
+ ( PUNCT O
4442
+ Mtb PROPN O
4443
+ ) PUNCT O
4444
+ bacilli NOUN O
4445
+ in ADP O
4446
+ nodule NOUN O
4447
+ and CCONJ O
4448
+ cavity NOUN O
4449
+ caseum NOUN O
4450
+ [ PUNCT O
4451
+ 29 NUM O
4452
+ ] PUNCT O
4453
+ , PUNCT O
4454
+ additional ADJ O
4455
+ population NOUN O
4456
+ PK NOUN B-AC
4457
+ / SYM O
4458
+ PD NOUN B-AC
4459
+ distributions NOUN O
4460
+ were AUX O
4461
+ simulated ADJ O
4462
+ using VERB O
4463
+ caseum NOUN B-LF
4464
+ - PUNCT I-LF
4465
+ specific ADJ I-LF
4466
+ minimum ADJ I-LF
4467
+ bactericidal ADJ I-LF
4468
+ concentration NOUN I-LF
4469
+ MBC90 PROPN O
4470
+ ( PUNCT O
4471
+ CasMBC90 PROPN B-AC
4472
+ ) PUNCT O
4473
+ as ADP O
4474
+ the DET O
4475
+ PD NOUN B-AC
4476
+ parameter NOUN O
4477
+ to PART O
4478
+ capture VERB O
4479
+ the DET O
4480
+ drugs NOUN O
4481
+ ’ PART O
4482
+ killing VERB O
4483
+ potential NOUN O
4484
+ in ADP O
4485
+ the DET O
4486
+ caseous ADJ O
4487
+ core NOUN O
4488
+ of ADP O
4489
+ necrotic ADJ O
4490
+ lesions NOUN O
4491
+ ( PUNCT O
4492
+ Fig PROPN O
4493
+ 9B NUM O
4494
+ ) PUNCT O
4495
+ . PUNCT O
4496
+ None NOUN O
4497
+ of ADP O
4498
+ the DET O
4499
+ drugs NOUN O
4500
+ were AUX O
4501
+ able ADJ O
4502
+ to PART O
4503
+ reach VERB O
4504
+ full ADJ O
4505
+ efficacy NOUN O
4506
+ in ADP O
4507
+ this DET O
4508
+ hard ADJ O
4509
+ - PUNCT O
4510
+ to PART O
4511
+ - PUNCT O
4512
+ treat VERB O
4513
+ lesion NOUN O
4514
+ , PUNCT O
4515
+ and CCONJ O
4516
+ MFX PROPN B-AC
4517
+ was AUX O
4518
+ the DET O
4519
+ only ADJ O
4520
+ drug NOUN O
4521
+ to PART O
4522
+ show VERB O
4523
+ efficacy NOUN O
4524
+ for ADP O
4525
+ 31 NUM O
4526
+ % NOUN O
4527
+ of ADP O
4528
+ the DET O
4529
+ simulated ADJ O
4530
+ population NOUN O
4531
+ . PUNCT O
4532
+
4533
+ Postnatal ADJ O
4534
+ weight NOUN O
4535
+ gain NOUN O
4536
+ in ADP O
4537
+ extremely ADV B-LF
4538
+ low ADJ I-LF
4539
+ birth NOUN I-LF
4540
+ weight NOUN I-LF
4541
+ infants NOUN I-LF
4542
+ ( PUNCT O
4543
+ ELBWIs PROPN B-AC
4544
+ ) PUNCT O
4545
+ is AUX O
4546
+ a DET O
4547
+ critical ADJ O
4548
+ issue NOUN O
4549
+ for ADP O
4550
+ neurodevelopment NOUN O
4551
+ outcomes NOUN O
4552
+ [ PUNCT O
4553
+ 1 NUM O
4554
+ ] PUNCT O
4555
+ . PUNCT O
4556
+
4557
+ MVC NOUN B-AC
4558
+ maximal ADJ O
4559
+ voluntary ADJ O
4560
+ contraction NOUN O
4561
+ , PUNCT O
4562
+ VA NOUN B-AC
4563
+ voluntary ADJ B-LF
4564
+ activation NOUN I-LF
4565
+ , PUNCT O
4566
+ LFF NOUN B-AC
4567
+ low ADJ B-LF
4568
+ frequency NOUN I-LF
4569
+ fatigue NOUN I-LF
4570
+ index NOUN O
4571
+ Db100Hz NOUN O
4572
+ double ADJ O
4573
+ electrical ADJ O
4574
+ pulse NOUN O
4575
+ at ADP O
4576
+ 100Hz NUM O
4577
+ , PUNCT O
4578
+ Db10Hz NOUN O
4579
+ double ADJ O
4580
+ electrical ADJ O
4581
+ pulse NOUN O
4582
+ at ADP O
4583
+ 10Hz NUM O
4584
+ , PUNCT O
4585
+ Single ADJ B-LF
4586
+ Twitch NOUN I-LF
4587
+ single ADJ O
4588
+ electrical ADJ O
4589
+ pulse NOUN O
4590
+ , PUNCT O
4591
+ ST PROPN B-AC
4592
+ - PUNCT O
4593
+ RFD PROPN B-AC
4594
+ Rate NOUN B-LF
4595
+ of ADP I-LF
4596
+ force NOUN I-LF
4597
+ development NOUN I-LF
4598
+ of ADP O
4599
+ single ADJ B-LF
4600
+ twitch NOUN I-LF
4601
+ , PUNCT O
4602
+ ST-½RRT PROPN B-AC
4603
+ Rate NOUN O
4604
+ of ADP O
4605
+ relaxation NOUN O
4606
+ of ADP O
4607
+ single ADJ B-LF
4608
+ twitch NOUN I-LF
4609
+ , PUNCT O
4610
+ ISR NOUN B-AC
4611
+ intra ADJ B-LF
4612
+ set NOUN I-LF
4613
+ rest NOUN I-LF
4614
+ configuration NOUN O
4615
+ , PUNCT O
4616
+ TS NOUN B-AC
4617
+ traditional ADJ B-LF
4618
+ set NOUN I-LF
4619
+ configuration NOUN O
4620
+ . PUNCT O
4621
+
4622
+ GDM NOUN B-AC
4623
+ , PUNCT O
4624
+ gestational ADJ B-LF
4625
+ diabetes NOUN I-LF
4626
+ mellitus NOUN I-LF
4627
+ ; PUNCT O
4628
+ PUFA NOUN B-AC
4629
+ , PUNCT O
4630
+ polyunsaturated ADJ B-LF
4631
+ fatty ADJ I-LF
4632
+ acid NOUN I-LF
4633
+ . PUNCT O
4634
+
4635
+ This DET O
4636
+ instrument NOUN O
4637
+ has VERB O
4638
+ the DET O
4639
+ advantage NOUN O
4640
+ of ADP O
4641
+ very ADV O
4642
+ sensitive ADJ B-LF
4643
+ avalanche NOUN I-LF
4644
+ photodiode NOUN I-LF
4645
+ detectors NOUN I-LF
4646
+ ( PUNCT O
4647
+ SPADs PROPN B-AC
4648
+ ) PUNCT O
4649
+ that PRON O
4650
+ are AUX O
4651
+ capable ADJ O
4652
+ at ADP O
4653
+ detecting VERB O
4654
+ nM NOUN O
4655
+ concentrations NOUN O
4656
+ of ADP O
4657
+ protein NOUN O
4658
+ . PUNCT O
4659
+
4660
+ uCTXII PROPN B-AC
4661
+ : PUNCT O
4662
+ C PROPN B-LF
4663
+ - PROPN I-LF
4664
+ Terminal PROPN I-LF
4665
+ Telopeptide NOUN I-LF
4666
+ type NOUN I-LF
4667
+ II NUM I-LF
4668
+
4669
+ DAPI PROPN B-AC
4670
+ ( PUNCT O
4671
+ 4′ NUM B-LF
4672
+ , PUNCT I-LF
4673
+ 6 NUM I-LF
4674
+ - PUNCT I-LF
4675
+ diamidino-2 NOUN I-LF
4676
+ - PUNCT I-LF
4677
+ phenylindole NOUN I-LF
4678
+ dihydrochloride NOUN I-LF
4679
+ ) PUNCT O
4680
+ was AUX O
4681
+ from ADP O
4682
+ Invitrogen PROPN O
4683
+ . PUNCT O
4684
+
4685
+ As ADP O
4686
+ with ADP O
4687
+ all DET O
4688
+ noncoding NOUN O
4689
+ sequences NOUN O
4690
+ , PUNCT O
4691
+ small ADJ O
4692
+ insertion NOUN B-LF
4693
+ or CCONJ I-LF
4694
+ deletion NOUN I-LF
4695
+ ( PUNCT O
4696
+ indel NOUN B-AC
4697
+ ) PUNCT O
4698
+ events NOUN O
4699
+ can AUX O
4700
+ also ADV O
4701
+ play VERB O
4702
+ important ADJ O
4703
+ roles NOUN O
4704
+ . PUNCT O
4705
+
4706
+ ( PUNCT O
4707
+ E NOUN O
4708
+ , PUNCT O
4709
+ F NOUN O
4710
+ , PUNCT O
4711
+ H NOUN O
4712
+ , PUNCT O
4713
+ and CCONJ O
4714
+ I NOUN O
4715
+ ) PUNCT O
4716
+ Red ADJ O
4717
+ and CCONJ O
4718
+ green ADJ O
4719
+ cholera NOUN B-LF
4720
+ toxin NOUN I-LF
4721
+ ( PUNCT O
4722
+ CT NOUN B-AC
4723
+ ) PUNCT O
4724
+ was AUX O
4725
+ injected VERB O
4726
+ into ADP O
4727
+ the DET O
4728
+ visual ADJ O
4729
+ ( PUNCT O
4730
+ V1 NOUN B-AC
4731
+ , PUNCT O
4732
+ open ADJ O
4733
+ arrowhead NOUN O
4734
+ in ADP O
4735
+ [ X O
4736
+ H NOUN O
4737
+ ] PUNCT O
4738
+ ) PUNCT O
4739
+ and CCONJ O
4740
+ somatosensory ADJ O
4741
+ ( PUNCT O
4742
+ S1 NOUN B-AC
4743
+ , PUNCT O
4744
+ open ADJ O
4745
+ arrowhead NOUN O
4746
+ in ADP O
4747
+ [ X O
4748
+ E NOUN O
4749
+ ] PUNCT O
4750
+ ) PUNCT O
4751
+ cortex NOUN O
4752
+ , PUNCT O
4753
+ respectively ADV O
4754
+ , PUNCT O
4755
+ of ADP O
4756
+ wild ADJ O
4757
+ - PUNCT O
4758
+ type NOUN O
4759
+ and CCONJ O
4760
+ Sema6A−/− NOUN O
4761
+ adult NOUN O
4762
+ mice NOUN O
4763
+ . PUNCT O
4764
+
4765
+ BCC PROPN B-AC
4766
+ , PUNCT O
4767
+ behavior NOUN B-LF
4768
+ change NOUN I-LF
4769
+ communication NOUN I-LF
4770
+ ; PUNCT O
4771
+ CNS PROPN B-AC
4772
+ , PUNCT O
4773
+ well ADJ O
4774
+ - PUNCT O
4775
+ baby NOUN O
4776
+ consultation PROPN O
4777
+ ( PUNCT O
4778
+ consultation PROPN O
4779
+ du X O
4780
+ nourrisson X O
4781
+ sain PROPN O
4782
+ ) PUNCT O
4783
+
4784
+ Subcortical ADJ O
4785
+ beta NOUN O
4786
+ bursting NOUN O
4787
+ is AUX O
4788
+ now ADV O
4789
+ a DET O
4790
+ target NOUN O
4791
+ for ADP O
4792
+ developing VERB O
4793
+ adaptive ADJ O
4794
+ deep ADJ B-LF
4795
+ brain NOUN I-LF
4796
+ stimulation NOUN I-LF
4797
+ ( PUNCT O
4798
+ DBS PROPN B-AC
4799
+ ) PUNCT O
4800
+ technologies NOUN O
4801
+ that PRON O
4802
+ seek VERB O
4803
+ to PART O
4804
+ directly ADV O
4805
+ reshape VERB O
4806
+ the DET O
4807
+ temporal ADJ O
4808
+ profile NOUN O
4809
+ of ADP O
4810
+ beta NOUN O
4811
+ events NOUN O
4812
+ and CCONJ O
4813
+ thereby ADV O
4814
+ provide VERB O
4815
+ evidence NOUN O
4816
+ for ADP O
4817
+ their PRON O
4818
+ causal ADJ O
4819
+ role NOUN O
4820
+ [ X O
4821
+ 70,74,86–88 NUM O
4822
+ ] PUNCT O
4823
+ . PUNCT O
4824
+
4825
+ Clinacanthus NOUN B-LF
4826
+ nutans NOUN I-LF
4827
+ ( PUNCT O
4828
+ CN PROPN B-AC
4829
+ ) PUNCT O
4830
+ has AUX O
4831
+ gained VERB O
4832
+ much ADJ O
4833
+ attention NOUN O
4834
+ because SCONJ O
4835
+ of ADP O
4836
+ its PRON O
4837
+ anticancer NOUN O
4838
+ properties NOUN O
4839
+ , PUNCT O
4840
+ but CCONJ O
4841
+ its PRON O
4842
+ mechanism NOUN O
4843
+ remains VERB O
4844
+ unclear ADJ O
4845
+ . PUNCT O
4846
+
4847
+ ILP1 PROPN B-AC
4848
+ also ADV O
4849
+ contains VERB O
4850
+ two NUM O
4851
+ cysteine NOUN O
4852
+ – PUNCT O
4853
+ cysteine NOUN O
4854
+ motifs NOUN O
4855
+ that PRON O
4856
+ are AUX O
4857
+ weakly ADV O
4858
+ predicted VERB O
4859
+ to PART O
4860
+ be AUX O
4861
+ palmitoylated VERB O
4862
+ by ADP O
4863
+ CSS PROPN O
4864
+ - PUNCT O
4865
+ PALM PROPN O
4866
+ [ PUNCT O
4867
+ 30 NUM O
4868
+ ] NOUN O
4869
+ , PUNCT O
4870
+ and CCONJ O
4871
+ thus ADV O
4872
+ a DET O
4873
+ quadruple ADJ B-LF
4874
+ C95S NOUN I-LF
4875
+ , PUNCT I-LF
4876
+ C96S PROPN I-LF
4877
+ , PUNCT I-LF
4878
+ C273S PROPN I-LF
4879
+ , PUNCT I-LF
4880
+ C274S PROPN I-LF
4881
+ mutant NOUN I-LF
4882
+ ( PUNCT O
4883
+ 4Cys NOUN B-AC
4884
+ ) PUNCT O
4885
+ was AUX O
4886
+ also ADV O
4887
+ generated VERB O
4888
+ . PUNCT O
4889
+
4890
+ CEA PROPN B-AC
4891
+ , PUNCT O
4892
+ carcinoembryonic ADJ B-LF
4893
+ antigen NOUN I-LF
4894
+ ; PUNCT O
4895
+ DD PROPN O
4896
+ , PUNCT O
4897
+ dedifferentiated VERB O
4898
+ ; PUNCT O
4899
+ FEV1 PROPN B-AC
4900
+ , PUNCT O
4901
+ forced VERB B-LF
4902
+ expiratory ADJ I-LF
4903
+ volume NOUN I-LF
4904
+ in ADP I-LF
4905
+ a DET I-LF
4906
+ second ADJ I-LF
4907
+ ; PUNCT O
4908
+ FVC PROPN B-AC
4909
+ , PUNCT O
4910
+ forced VERB B-LF
4911
+ vital ADJ I-LF
4912
+ capacity NOUN I-LF
4913
+ ; PUNCT O
4914
+ MD PROPN O
4915
+ , PUNCT O
4916
+ moderately ADV O
4917
+ differentiated VERB O
4918
+ ; PUNCT O
4919
+ PD PROPN O
4920
+ , PUNCT O
4921
+ poorly ADV O
4922
+ differentiated VERB O
4923
+ ; PUNCT O
4924
+ WD PROPN O
4925
+ , PUNCT O
4926
+ well ADV O
4927
+ - PUNCT O
4928
+ differentiated VERB O
4929
+ . PUNCT O
4930
+
4931
+ It PRON O
4932
+ is AUX O
4933
+ a DET O
4934
+ gelatine NOUN O
4935
+ based VERB O
4936
+ biodegradable ADJ O
4937
+ slow ADV O
4938
+ - PUNCT O
4939
+ releasing VERB O
4940
+ - PUNCT O
4941
+ device NOUN O
4942
+ containing VERB O
4943
+ 33 NUM O
4944
+ % NOUN O
4945
+ ( PUNCT O
4946
+ 2.5 NUM O
4947
+ mg NOUN O
4948
+ ) PUNCT O
4949
+ CHX PROPN B-AC
4950
+ . PUNCT O
4951
+ This DET O
4952
+ small ADJ O
4953
+ chip NOUN O
4954
+ ( PUNCT O
4955
+ 5 NUM O
4956
+ mm NOUN O
4957
+ x SYM O
4958
+ 4 NUM O
4959
+ mm NOUN O
4960
+ x SYM O
4961
+ 0.35 NUM O
4962
+ mm NOUN O
4963
+ , PUNCT O
4964
+ 7 NUM O
4965
+ mg NOUN O
4966
+ ) PUNCT O
4967
+ is AUX O
4968
+ placed VERB O
4969
+ in ADP O
4970
+ periodontal ADJ O
4971
+ pockets NOUN O
4972
+ and CCONJ O
4973
+ releases VERB O
4974
+ CHX PROPN B-AC
4975
+ for ADP O
4976
+ over ADP O
4977
+ 7 NUM O
4978
+ days NOUN O
4979
+ in ADP O
4980
+ clinical ADJ O
4981
+ settings NOUN O
4982
+ . PUNCT O
4983
+ [ X O
4984
+ 15 X O
4985
+ ] X O
4986
+ The DET O
4987
+ second ADJ O
4988
+ is AUX O
4989
+ a DET O
4990
+ xanthan NOUN O
4991
+ based VERB O
4992
+ gel NOUN O
4993
+ , PUNCT O
4994
+ called VERB O
4995
+ Chlosite PROPN O
4996
+ , PUNCT O
4997
+ containing VERB O
4998
+ 0.5 NUM O
4999
+ % NOUN O
5000
+ chlorhexidine- NOUN B-LF
5001
+ digluconate NOUN O
5002
+ and CCONJ O
5003
+ 1.0 NUM O
5004
+ % NOUN O
5005
+ of ADP O
5006
+ – PUNCT O
5007
+ dihydrochlorite NOUN O
5008
+ . PUNCT O
5009
+
5010
+ Viability NOUN O
5011
+ of ADP O
5012
+ the DET O
5013
+ embryos NOUN O
5014
+ was AUX O
5015
+ checked VERB O
5016
+ at ADP O
5017
+ the DET O
5018
+ indicated VERB O
5019
+ time NOUN O
5020
+ points NOUN O
5021
+ ( PUNCT O
5022
+ EDD PROPN B-AC
5023
+ = PUNCT O
5024
+ embryonic ADJ B-LF
5025
+ development NOUN I-LF
5026
+ day NOUN I-LF
5027
+ ) PUNCT O
5028
+ . PUNCT O
5029
+
5030
+ The DET O
5031
+ package NOUN O
5032
+ of ADP O
5033
+ CoC PROPN B-AC
5034
+ interventions NOUN O
5035
+ improved VERB O
5036
+ CoC PROPN B-AC
5037
+ completion NOUN O
5038
+ ( PUNCT O
5039
+ adjusted VERB B-LF
5040
+ odds NOUN I-LF
5041
+ ratio NOUN I-LF
5042
+ [ PUNCT O
5043
+ AOR NOUN B-AC
5044
+ ] PUNCT O
5045
+ for ADP O
5046
+ DiD PROPN B-AC
5047
+ = SYM O
5048
+ 1.77 NUM O
5049
+ ; PUNCT O
5050
+ 95 NUM O
5051
+ % NOUN O
5052
+ confidence NOUN B-LF
5053
+ interval NOUN I-LF
5054
+ [ PUNCT O
5055
+ CI NOUN B-AC
5056
+ ] PUNCT O
5057
+ : PUNCT O
5058
+ 1.08 NUM O
5059
+ to PART O
5060
+ 2.92 NUM O
5061
+ ; PUNCT O
5062
+ p NOUN O
5063
+ = SYM O
5064
+ 0.024 NUM O
5065
+ ) PUNCT O
5066
+ . PUNCT O
5067
+
5068
+ DMT PROPN B-AC
5069
+ , PUNCT O
5070
+ disease NOUN B-LF
5071
+ - PUNCT I-LF
5072
+ modifying VERB I-LF
5073
+ therapy NOUN I-LF
5074
+ ; PUNCT O
5075
+ ICD PROPN B-AC
5076
+ , PUNCT O
5077
+ International PROPN B-LF
5078
+ Classification PROPN I-LF
5079
+ of ADP I-LF
5080
+ Diseases PROPN I-LF
5081
+ ; PUNCT O
5082
+ MS PROPN B-AC
5083
+ , PUNCT O
5084
+ multiple ADJ B-LF
5085
+ sclerosis NOUN I-LF
5086
+ . PUNCT O
5087
+
5088
+ The DET O
5089
+ Systolic PROPN B-LF
5090
+ Blood PROPN I-LF
5091
+ Pressure PROPN I-LF
5092
+ Intervention PROPN I-LF
5093
+ Trial PROPN I-LF
5094
+ ( PUNCT O
5095
+ SPRINT PROPN B-AC
5096
+ ) PUNCT O
5097
+ and CCONJ O
5098
+ the DET O
5099
+ Heart PROPN B-LF
5100
+ Outcomes PROPN I-LF
5101
+ Prevention PROPN I-LF
5102
+ Evaluation-3 PROPN I-LF
5103
+ ( PUNCT O
5104
+ HOPE-3 PROPN B-AC
5105
+ ) PUNCT O
5106
+ study NOUN O
5107
+ provide VERB O
5108
+ data NOUN O
5109
+ that PRON O
5110
+ complement VERB O
5111
+ our PRON O
5112
+ analyses NOUN O
5113
+ and CCONJ O
5114
+ support VERB O
5115
+ these DET O
5116
+ results NOUN O
5117
+ [ PUNCT O
5118
+ 32,33 NUM O
5119
+ ] PUNCT O
5120
+ . PUNCT O
5121
+
5122
+ NFATs NOUN B-AC
5123
+ often ADV O
5124
+ up ADV O
5125
+ - PROPN O
5126
+ regulate VERB O
5127
+ gene NOUN O
5128
+ transcription NOUN O
5129
+ in ADP O
5130
+ cooperation NOUN O
5131
+ with ADP O
5132
+ other ADJ O
5133
+ transcription NOUN O
5134
+ factors NOUN O
5135
+ , PUNCT O
5136
+ most ADV O
5137
+ commonly ADV O
5138
+ AP-1 PROPN O
5139
+ , PUNCT O
5140
+ the DET O
5141
+ combination NOUN O
5142
+ being AUX O
5143
+ required VERB O
5144
+ for ADP O
5145
+ the DET O
5146
+ expression NOUN O
5147
+ of ADP O
5148
+ interleukin NOUN B-LF
5149
+ ( PUNCT O
5150
+ IL)-2 NOUN B-AC
5151
+ [ PUNCT O
5152
+ 6 NUM O
5153
+ ] PUNCT O
5154
+ , PUNCT O
5155
+ IL-3 NOUN B-AC
5156
+ [ PUNCT O
5157
+ 7 NUM O
5158
+ ] PUNCT O
5159
+ , PUNCT O
5160
+ granulocyte NOUN B-LF
5161
+ - PROPN I-LF
5162
+ macrophage NOUN I-LF
5163
+ colony NOUN I-LF
5164
+ - PROPN I-LF
5165
+ stimulating VERB I-LF
5166
+ factor NOUN I-LF
5167
+ ( PUNCT O
5168
+ GM PROPN B-AC
5169
+ - PROPN B-AC
5170
+ CSF PROPN B-AC
5171
+ ) PUNCT O
5172
+ [ PUNCT O
5173
+ 8 NUM O
5174
+ ] PUNCT O
5175
+ , PUNCT O
5176
+ IL-4 NOUN B-AC
5177
+ [ PUNCT O
5178
+ 9 NUM O
5179
+ ] PUNCT O
5180
+ , PUNCT O
5181
+ IL-5 NOUN B-AC
5182
+ [ PUNCT O
5183
+ 10 NUM O
5184
+ ] PUNCT O
5185
+ , PUNCT O
5186
+ IL-13 NOUN B-AC
5187
+ [ PUNCT O
5188
+ 6 NUM O
5189
+ ] PUNCT O
5190
+ , PUNCT O
5191
+ interferon NOUN B-LF
5192
+ gamma NOUN I-LF
5193
+ ( PUNCT O
5194
+ IFN PROPN B-AC
5195
+ - PROPN B-AC
5196
+ γ PROPN B-AC
5197
+ ) PUNCT O
5198
+ [ PUNCT O
5199
+ 11 NUM O
5200
+ ] PUNCT O
5201
+ , PUNCT O
5202
+ Fas NOUN B-LF
5203
+ ligand NOUN I-LF
5204
+ ( PUNCT O
5205
+ FasL PROPN B-AC
5206
+ ) PUNCT O
5207
+ [ PUNCT O
5208
+ 12 NUM O
5209
+ ] PUNCT O
5210
+ , PUNCT O
5211
+ CD25 NOUN O
5212
+ [ PUNCT O
5213
+ 13 NUM O
5214
+ ] PUNCT O
5215
+ , PUNCT O
5216
+ Cox2 NOUN O
5217
+ [ PUNCT O
5218
+ 14 NUM O
5219
+ ] PUNCT O
5220
+ , PUNCT O
5221
+ IL-8 NOUN B-AC
5222
+ , PUNCT O
5223
+ and CCONJ O
5224
+ migration NOUN B-LF
5225
+ inhibitory ADJ I-LF
5226
+ factor NOUN I-LF
5227
+ 1 NUM I-LF
5228
+ alpha NOUN I-LF
5229
+ ( PUNCT O
5230
+ MIF-1α PROPN B-AC
5231
+ ) PUNCT O
5232
+ [ PUNCT O
5233
+ 11 NUM O
5234
+ ] PUNCT O
5235
+ . PUNCT O
5236
+
5237
+ The DET O
5238
+ Pseudomonas PROPN O
5239
+ aeruginosa NOUN O
5240
+ MvfR PROPN O
5241
+ - PUNCT O
5242
+ dependent ADJ O
5243
+ QS NOUN B-AC
5244
+ regulatory ADJ O
5245
+ pathway NOUN O
5246
+ controls VERB O
5247
+ the DET O
5248
+ expression NOUN O
5249
+ of ADP O
5250
+ key ADJ O
5251
+ virulence NOUN O
5252
+ genes NOUN O
5253
+ ; PUNCT O
5254
+ and CCONJ O
5255
+ is AUX O
5256
+ activated VERB O
5257
+ via ADP O
5258
+ the DET O
5259
+ extracellular ADJ O
5260
+ signals NOUN O
5261
+ 4 NUM B-LF
5262
+ - PUNCT I-LF
5263
+ hydroxy-2 NOUN I-LF
5264
+ - PUNCT I-LF
5265
+ heptylquinoline NOUN I-LF
5266
+ ( PUNCT O
5267
+ HHQ PROPN B-AC
5268
+ ) PUNCT O
5269
+ and CCONJ O
5270
+ 3,4 NUM B-LF
5271
+ - PUNCT I-LF
5272
+ dihydroxy-2 NOUN I-LF
5273
+ - PUNCT I-LF
5274
+ heptylquinoline NOUN I-LF
5275
+ ( PUNCT O
5276
+ PQS PROPN B-AC
5277
+ ) PUNCT O
5278
+ , PUNCT O
5279
+ whose DET O
5280
+ syntheses NOUN O
5281
+ depend VERB O
5282
+ on ADP O
5283
+ anthranilic ADJ B-LF
5284
+ acid NOUN I-LF
5285
+ ( PUNCT O
5286
+ AA PROPN B-AC
5287
+ ) PUNCT O
5288
+ , PUNCT O
5289
+ the DET O
5290
+ primary ADJ O
5291
+ precursor NOUN O
5292
+ of ADP O
5293
+ 4 NUM B-LF
5294
+ - PUNCT I-LF
5295
+ hydroxy-2 NOUN I-LF
5296
+ - PUNCT I-LF
5297
+ alkylquinolines NOUN I-LF
5298
+ ( PUNCT O
5299
+ HAQs PROPN B-AC
5300
+ ) PUNCT O
5301
+ . PUNCT O
5302
+
5303
+ The DET O
5304
+ various ADJ O
5305
+ aminoalcohol NOUN O
5306
+ derivatives NOUN O
5307
+ , PUNCT O
5308
+ including VERB O
5309
+ 2-(ethylamino)ethanol NOUN O
5310
+ , PUNCT O
5311
+ N NOUN O
5312
+ - NOUN O
5313
+ methylethanolamine NOUN O
5314
+ , PUNCT O
5315
+ diethanolamine NOUN O
5316
+ , PUNCT O
5317
+ and CCONJ O
5318
+ triethanolamine NOUN O
5319
+ , PUNCT O
5320
+ have AUX O
5321
+ been AUX O
5322
+ verified VERB O
5323
+ as ADP O
5324
+ activators NOUN O
5325
+ to PART O
5326
+ enhance VERB O
5327
+ bovine ADJ B-LF
5328
+ intestine NOUN I-LF
5329
+ ALP NOUN I-LF
5330
+ ( PUNCT O
5331
+ BIALP PROPN B-AC
5332
+ ) PUNCT O
5333
+ activity NOUN O
5334
+ to PART O
5335
+ degrade VERB O
5336
+ p NOUN B-LF
5337
+ - NOUN I-LF
5338
+ nitrophenyl NOUN I-LF
5339
+ phosphate NOUN I-LF
5340
+ ( PUNCT O
5341
+ pNPP NOUN B-AC
5342
+ ) PUNCT O
5343
+ [ PUNCT O
5344
+ 20 NUM O
5345
+ ] PUNCT O
5346
+ . PUNCT O
5347
+
5348
+ The DET O
5349
+ mean ADJ O
5350
+ ( PUNCT O
5351
+ 95 NUM O
5352
+ % NOUN O
5353
+ confidence NOUN O
5354
+ interval NOUN O
5355
+ ) NOUN O
5356
+ diagnostic ADJ O
5357
+ accuracy NOUN O
5358
+ of ADP O
5359
+ selected VERB O
5360
+ modalities NOUN O
5361
+ was AUX O
5362
+ as SCONJ O
5363
+ follows VERB O
5364
+ : PUNCT O
5365
+ Meckel PROPN B-AC
5366
+ ’s PART B-AC
5367
+ scan NOUN B-AC
5368
+ , PUNCT O
5369
+ 21.4 NUM O
5370
+ % NOUN O
5371
+ ( PUNCT O
5372
+ 5.7%-51.2 NUM O
5373
+ % NOUN O
5374
+ ) NOUN O
5375
+ ; PUNCT O
5376
+ capsule NOUN O
5377
+ endoscopy NOUN O
5378
+ , PUNCT O
5379
+ 35.7 NUM O
5380
+ % NOUN O
5381
+ ( PUNCT O
5382
+ 14.0%-64.4 NUM O
5383
+ % NOUN O
5384
+ ) NOUN O
5385
+ ; PUNCT O
5386
+ balloon NOUN B-LF
5387
+ - PUNCT I-LF
5388
+ assisted VERB I-LF
5389
+ enteroscopy NOUN I-LF
5390
+ ( PUNCT O
5391
+ BAE PROPN B-AC
5392
+ ) NOUN O
5393
+ , PUNCT O
5394
+ 85.0 NUM O
5395
+ % NOUN O
5396
+ ( PUNCT O
5397
+ 61.1%-96.0 NUM O
5398
+ % NOUN O
5399
+ ) NOUN O
5400
+ ; PUNCT O
5401
+ angiography NOUN O
5402
+ , PUNCT O
5403
+ 0.0 NUM O
5404
+ % NOUN O
5405
+ ( PUNCT O
5406
+ 0.0%-80.2 NUM O
5407
+ % NOUN O
5408
+ ) NOUN O
5409
+ ; PUNCT O
5410
+ computed VERB O
5411
+ tomography NOUN O
5412
+ , PUNCT O
5413
+ 31.8 NUM O
5414
+ % NOUN O
5415
+ ( PUNCT O
5416
+ 14.7%-54.9 NUM O
5417
+ % NOUN O
5418
+ ) NOUN O
5419
+ ; PUNCT O
5420
+ and CCONJ O
5421
+ small ADJ O
5422
+ - PUNCT O
5423
+ bowel NOUN O
5424
+ follow NOUN O
5425
+ - PUNCT O
5426
+ through NOUN O
5427
+ , PUNCT O
5428
+ 62.5 NUM O
5429
+ % NOUN O
5430
+ ( PUNCT O
5431
+ 25.9%-90.0 NUM O
5432
+ % NOUN O
5433
+ ) NOUN O
5434
+ . NOUN O
5435
+
5436
+ PE PROPN B-AC
5437
+ = PUNCT O
5438
+ Patient NOUN B-LF
5439
+ Empowerment NOUN I-LF
5440
+ , PUNCT O
5441
+ GSE PROPN B-AC
5442
+ = PUNCT O
5443
+ General PROPN B-LF
5444
+ Self PROPN I-LF
5445
+ - PUNCT I-LF
5446
+ Efficacy NOUN I-LF
5447
+ , PUNCT O
5448
+ TCS PROPN B-AC
5449
+ = PUNCT O
5450
+ Transition PROPN B-LF
5451
+ Competence NOUN I-LF
5452
+ Scale NOUN I-LF
5453
+ , PUNCT O
5454
+ PAM PROPN B-AC
5455
+ = PUNCT O
5456
+ Patient NOUN O
5457
+ Activation PROPN O
5458
+ Measurement PROPN O
5459
+ – PUNCT O
5460
+ German PROPN O
5461
+ Youth PROPN O
5462
+ Version PROPN O
5463
+ . PUNCT O
5464
+
5465
+ Developmental ADJ O
5466
+ task NOUN O
5467
+ - PUNCT O
5468
+ based VERB O
5469
+ functional ADJ B-LF
5470
+ magnetic ADJ I-LF
5471
+ resonance NOUN I-LF
5472
+ imaging NOUN I-LF
5473
+ ( PUNCT O
5474
+ fMRI NOUN B-AC
5475
+ ) PUNCT O
5476
+ studies NOUN O
5477
+ indicate VERB O
5478
+ that SCONJ O
5479
+ core NOUN O
5480
+ regions NOUN O
5481
+ supporting VERB O
5482
+ cognitive ADJ O
5483
+ control NOUN O
5484
+ ( PUNCT O
5485
+ e.g. X O
5486
+ , PUNCT O
5487
+ anterior ADJ B-LF
5488
+ cingulate NOUN I-LF
5489
+ cortex NOUN I-LF
5490
+ [ X O
5491
+ ACC PROPN B-AC
5492
+ ] PUNCT O
5493
+ and CCONJ O
5494
+ anterior ADJ B-LF
5495
+ insula NOUN I-LF
5496
+ [ X O
5497
+ aIns NOUN B-AC
5498
+ ] PUNCT O
5499
+ ) PUNCT O
5500
+ are AUX O
5501
+ engaged VERB O
5502
+ in ADP O
5503
+ adolescence NOUN O
5504
+ during ADP O
5505
+ cognitive ADJ O
5506
+ tasks NOUN O
5507
+ , PUNCT O
5508
+ but CCONJ O
5509
+ their PRON O
5510
+ blood NOUN B-LF
5511
+ oxygen NOUN I-LF
5512
+ level NOUN I-LF
5513
+ – PUNCT I-LF
5514
+ dependent ADJ I-LF
5515
+ ( PUNCT O
5516
+ BOLD PROPN B-AC
5517
+ ) PUNCT O
5518
+ signal NOUN O
5519
+ activation NOUN O
5520
+ [ X O
5521
+ 3,4 NUM O
5522
+ ] PUNCT O
5523
+ and CCONJ O
5524
+ connectivity NOUN O
5525
+ with ADP O
5526
+ other ADJ O
5527
+ brain NOUN O
5528
+ regions NOUN O
5529
+ continue VERB O
5530
+ to PART O
5531
+ increase VERB O
5532
+ into ADP O
5533
+ adulthood NOUN O
5534
+ [ X O
5535
+ 5–7 NUM O
5536
+ ] PUNCT O
5537
+ . PUNCT O
5538
+
5539
+ A DET O
5540
+ candidate NOUN O
5541
+ target NOUN O
5542
+ pathway NOUN O
5543
+ is AUX O
5544
+ quorum NOUN B-LF
5545
+ sensing NOUN I-LF
5546
+ ( PUNCT O
5547
+ QS PROPN B-AC
5548
+ ) PUNCT O
5549
+ , PUNCT O
5550
+ which PRON O
5551
+ many ADJ O
5552
+ bacterial ADJ O
5553
+ pathogens NOUN O
5554
+ use VERB O
5555
+ to PART O
5556
+ coordinately ADV O
5557
+ regulate VERB O
5558
+ virulence NOUN O
5559
+ determinants NOUN O
5560
+ . PUNCT O
5561
+
5562
+ Wall NOUN B-LF
5563
+ - PUNCT I-LF
5564
+ associated VERB I-LF
5565
+ kinases NOUN I-LF
5566
+ ( PUNCT O
5567
+ WAKs PROPN B-AC
5568
+ ) PUNCT O
5569
+ comprise VERB O
5570
+ a DET O
5571
+ subfamily NOUN O
5572
+ of ADP O
5573
+ proteins NOUN O
5574
+ within ADP O
5575
+ the DET O
5576
+ receptor NOUN B-LF
5577
+ - PUNCT I-LF
5578
+ like ADJ I-LF
5579
+ kinase NOUN I-LF
5580
+ ( PUNCT O
5581
+ RLK PROPN B-AC
5582
+ ) PUNCT O
5583
+ superfamily NOUN O
5584
+ . PUNCT O
5585
+
5586
+ Early ADJ B-LF
5587
+ repolarization NOUN I-LF
5588
+ pattern NOUN I-LF
5589
+ ( PUNCT O
5590
+ ERP NOUN B-AC
5591
+ ) PUNCT O
5592
+ on ADP O
5593
+ electrocardiogram NOUN O
5594
+ was AUX O
5595
+ associated VERB O
5596
+ with ADP O
5597
+ idiopathic ADJ O
5598
+ ventricular ADJ O
5599
+ fibrillation NOUN O
5600
+ and CCONJ O
5601
+ sudden ADJ O
5602
+ cardiac ADJ O
5603
+ arrest NOUN O
5604
+ in ADP O
5605
+ a DET O
5606
+ case NOUN O
5607
+ - PUNCT O
5608
+ control NOUN O
5609
+ study NOUN O
5610
+ and CCONJ O
5611
+ with ADP O
5612
+ cardiovascular ADJ O
5613
+ mortality NOUN O
5614
+ in ADP O
5615
+ a DET O
5616
+ Finnish ADJ O
5617
+ community NOUN O
5618
+ - PUNCT O
5619
+ based VERB O
5620
+ sample NOUN O
5621
+ . PUNCT O
5622
+
5623
+ NF54CSA PROPN B-AC
5624
+ , PUNCT O
5625
+ Plasmodium NOUN O
5626
+ falciparum NOUN O
5627
+ isolate NOUN O
5628
+ NF54 PROPN B-AC
5629
+ selected VERB O
5630
+ for ADP O
5631
+ CSA NOUN B-AC
5632
+ adhesion NOUN O
5633
+ ; PUNCT O
5634
+ VAR2CSA PROPN B-AC
5635
+ , PUNCT O
5636
+ variant NOUN B-LF
5637
+ surface NOUN I-LF
5638
+ antigen NOUN I-LF
5639
+ 2 NUM I-LF
5640
+ - PUNCT I-LF
5641
+ CSA NOUN I-LF
5642
+ ; PUNCT O
5643
+ T934A PROPN O
5644
+ , PUNCT O
5645
+ threonine934 NOUN O
5646
+ alanine NOUN O
5647
+ . PUNCT O
5648
+
5649
+ Age NOUN O
5650
+ - PUNCT O
5651
+ standardized VERB O
5652
+ incidence NOUN O
5653
+ rates NOUN O
5654
+ ( PUNCT O
5655
+ per ADP O
5656
+ million NUM O
5657
+ person NOUN O
5658
+ - PUNCT O
5659
+ years NOUN O
5660
+ ) PUNCT O
5661
+ in ADP O
5662
+ males NOUN O
5663
+ and CCONJ O
5664
+ females NOUN O
5665
+ were AUX O
5666
+ 34.0 NUM O
5667
+ ( PUNCT O
5668
+ 95 NUM B-LF
5669
+ % NOUN I-LF
5670
+ confidence NOUN I-LF
5671
+ interval NOUN I-LF
5672
+ [ PUNCT O
5673
+ CI NOUN O
5674
+ ] X O
5675
+ 28.9–39.1 NUM O
5676
+ ) PUNCT O
5677
+ and CCONJ O
5678
+ 26.2 NUM O
5679
+ ( PUNCT O
5680
+ 95 NUM B-AC
5681
+ % NOUN B-AC
5682
+ CI NOUN B-AC
5683
+ 21.5–30.7 NUM O
5684
+ ) PUNCT O
5685
+ for ADP O
5686
+ LL PROPN B-AC
5687
+ , PUNCT O
5688
+ 10.5 NUM O
5689
+ ( PUNCT O
5690
+ 95 NUM B-AC
5691
+ % NOUN B-AC
5692
+ CI NOUN B-AC
5693
+ 7.7–13.3 NUM O
5694
+ ) PUNCT O
5695
+ and CCONJ O
5696
+ 12.5 NUM O
5697
+ ( PUNCT O
5698
+ 95 NUM B-AC
5699
+ % NOUN B-AC
5700
+ CI NOUN B-AC
5701
+ 9.4–15.7 NUM O
5702
+ ) PUNCT O
5703
+ for ADP O
5704
+ HL PROPN B-AC
5705
+ , PUNCT O
5706
+ 12.5 NUM O
5707
+ ( PUNCT O
5708
+ 95 NUM B-AC
5709
+ % NOUN B-AC
5710
+ CI NOUN B-AC
5711
+ 9.3–15.4 NUM O
5712
+ ) PUNCT O
5713
+ and CCONJ O
5714
+ 7.7 NUM O
5715
+ ( PUNCT O
5716
+ 95 NUM B-AC
5717
+ % NOUN B-AC
5718
+ CI NOUN B-AC
5719
+ 5.2–10.2 NUM O
5720
+ ) PUNCT O
5721
+ for ADP O
5722
+ NHL PROPN B-AC
5723
+ ( PUNCT O
5724
+ except SCONJ O
5725
+ for ADP O
5726
+ Burkitt PROPN O
5727
+ lymphomas NOUN O
5728
+ ) PUNCT O
5729
+ , PUNCT O
5730
+ and CCONJ O
5731
+ 3.2 NUM O
5732
+ ( PUNCT O
5733
+ 95 NUM B-AC
5734
+ % NOUN B-AC
5735
+ CI NOUN B-AC
5736
+ 1.6–4.7 NUM O
5737
+ ) PUNCT O
5738
+ and CCONJ O
5739
+ 1.5 NUM O
5740
+ ( PUNCT O
5741
+ 95 NUM B-AC
5742
+ % NOUN B-AC
5743
+ CI NOUN B-AC
5744
+ 0.4–2.5 NUM O
5745
+ ) PUNCT O
5746
+ for ADP O
5747
+ Burkitt PROPN O
5748
+ lymphomas NOUN O
5749
+ . PUNCT O
5750
+
5751
+ AMPA PROPN B-AC
5752
+ , PUNCT O
5753
+ α NOUN B-LF
5754
+ - PUNCT I-LF
5755
+ amino-3 NOUN I-LF
5756
+ - PUNCT I-LF
5757
+ hydroxy-5 NOUN I-LF
5758
+ - PUNCT I-LF
5759
+ methyl-4 NOUN I-LF
5760
+ - PUNCT I-LF
5761
+ isoxazolepropionic NOUN I-LF
5762
+ acid NOUN I-LF
5763
+ ; PUNCT O
5764
+ DiSs PROPN B-AC
5765
+ , PUNCT O
5766
+ dually ADV B-LF
5767
+ innervated VERB I-LF
5768
+ spines NOUN I-LF
5769
+ ; PUNCT O
5770
+ EPSP PROPN B-AC
5771
+ , PUNCT O
5772
+ excitatory ADJ B-LF
5773
+ postsynaptic ADJ I-LF
5774
+ potential NOUN I-LF
5775
+ ; PUNCT O
5776
+ IPSP PROPN B-AC
5777
+ , PUNCT O
5778
+ inhibitory ADJ B-LF
5779
+ postsynaptic ADJ I-LF
5780
+ potential NOUN I-LF
5781
+ ; PUNCT O
5782
+ NMDA PROPN B-AC
5783
+ , PUNCT O
5784
+ N NOUN B-LF
5785
+ - PUNCT I-LF
5786
+ Methyl NOUN I-LF
5787
+ - PUNCT I-LF
5788
+ D NOUN I-LF
5789
+ - PUNCT I-LF
5790
+ aspartate NOUN I-LF
5791
+ . PUNCT O
5792
+
5793
+ AFP PROPN B-AC
5794
+ , PUNCT O
5795
+ α NOUN B-LF
5796
+ - PUNCT I-LF
5797
+ fetoprotein NOUN I-LF
5798
+ ; PUNCT O
5799
+ ALT PROPN B-AC
5800
+ , PUNCT O
5801
+ alanine NOUN B-LF
5802
+ transaminase NOUN I-LF
5803
+ ; PUNCT O
5804
+ CLIP PROPN B-AC
5805
+ , PUNCT O
5806
+ Cancer PROPN B-LF
5807
+ of ADP I-LF
5808
+ the DET I-LF
5809
+ Liver PROPN I-LF
5810
+ Italian PROPN I-LF
5811
+ Program PROPN I-LF
5812
+ ; PUNCT O
5813
+ CTP PROPN B-AC
5814
+ , PUNCT O
5815
+ Child PROPN B-LF
5816
+ - PUNCT I-LF
5817
+ Turcotte PROPN I-LF
5818
+ - PUNCT I-LF
5819
+ Pugh PROPN I-LF
5820
+ ; PUNCT O
5821
+ HBsAg PROPN B-AC
5822
+ , PUNCT O
5823
+ hepatitis NOUN B-LF
5824
+ B NOUN I-LF
5825
+ surface NOUN I-LF
5826
+ antigen NOUN I-LF
5827
+ ; PUNCT O
5828
+ HCV PROPN B-AC
5829
+ , PUNCT O
5830
+ hepatitis NOUN O
5831
+ C NOUN O
5832
+ ; PUNCT O
5833
+ INR NOUN B-AC
5834
+ , PUNCT O
5835
+ international ADJ B-LF
5836
+ normalized VERB I-LF
5837
+ ratio NOUN I-LF
5838
+ ; PUNCT O
5839
+ MELD PROPN B-AC
5840
+ , PUNCT O
5841
+ model NOUN B-LF
5842
+ for ADP I-LF
5843
+ end ADJ I-LF
5844
+ - PUNCT I-LF
5845
+ stage NOUN I-LF
5846
+ liver NOUN I-LF
5847
+ disease NOUN I-LF
5848
+ ; PUNCT O
5849
+ PT PROPN B-AC
5850
+ , PUNCT O
5851
+ prothrombin NOUN B-LF
5852
+ time NOUN I-LF
5853
+ ; PUNCT O
5854
+ SD PROPN B-AC
5855
+ , PUNCT O
5856
+ standard ADJ B-LF
5857
+ deviation NOUN I-LF
5858
+ ; PUNCT O
5859
+ SR PROPN B-AC
5860
+ , PUNCT O
5861
+ surgical ADJ B-LF
5862
+ resection NOUN I-LF
5863
+ ; PUNCT O
5864
+ TACE PROPN B-AC
5865
+ , PUNCT O
5866
+ transarterial ADJ B-LF
5867
+ chemoembolization NOUN I-LF
5868
+ ; PUNCT O
5869
+ TIS PROPN B-AC
5870
+ , PUNCT O
5871
+ Taipei PROPN B-LF
5872
+ Integrated PROPN I-LF
5873
+ Scoring PROPN I-LF
5874
+ System PROPN I-LF
5875
+
5876
+ GLM PROPN B-AC
5877
+ , PUNCT O
5878
+ general ADJ B-LF
5879
+ linear ADJ I-LF
5880
+ model NOUN I-LF
5881
+ ; PUNCT O
5882
+ OFC PROPN B-AC
5883
+ , PUNCT O
5884
+ orbitofrontal ADJ B-LF
5885
+ cortex NOUN I-LF
5886
+ . PUNCT O
5887
+
5888
+ NSAID PROPN B-AC
5889
+ , PUNCT O
5890
+ non ADJ B-LF
5891
+ - PUNCT I-LF
5892
+ steroidal ADJ I-LF
5893
+ anti ADJ I-LF
5894
+ - PUNCT I-LF
5895
+ inflammatory ADJ I-LF
5896
+ drug NOUN I-LF
5897
+ ; PUNCT O
5898
+ RT PROPN O
5899
+ - PUNCT O
5900
+ PCR PROPN O
5901
+ , PUNCT O
5902
+ reverse ADJ O
5903
+ transcription NOUN O
5904
+ polymerase NOUN O
5905
+ chain NOUN O
5906
+ reaction NOUN O
5907
+ ; PUNCT O
5908
+ SARS PROPN B-AC
5909
+ - PUNCT B-AC
5910
+ CoV-2 PROPN B-AC
5911
+ , PUNCT O
5912
+ severe ADJ B-LF
5913
+ acute ADJ I-LF
5914
+ respiratory ADJ I-LF
5915
+ syndrome NOUN I-LF
5916
+ coronavirus NOUN I-LF
5917
+ 2 NUM I-LF
5918
+ . PUNCT O
5919
+
5920
+ AUD PROPN O
5921
+ , PUNCT O
5922
+ Australian ADJ O
5923
+ dollars NOUN O
5924
+ ; PUNCT O
5925
+ DALY PROPN B-AC
5926
+ , PUNCT O
5927
+ disability NOUN B-LF
5928
+ - PUNCT I-LF
5929
+ adjusted VERB I-LF
5930
+ life NOUN I-LF
5931
+ year NOUN I-LF
5932
+ ; PUNCT O
5933
+ NZ PROPN O
5934
+ , PUNCT O
5935
+ New PROPN O
5936
+ Zealand PROPN O
5937
+ . PUNCT O
5938
+
5939
+ Data PROPN O
5940
+ - PUNCT O
5941
+ sharing NOUN O
5942
+ platforms NOUN O
5943
+ such ADJ O
5944
+ as ADP O
5945
+ Clinical PROPN O
5946
+ Study PROPN O
5947
+ Data PROPN O
5948
+ Request PROPN O
5949
+ , PUNCT O
5950
+ the DET O
5951
+ Yale PROPN B-LF
5952
+ University PROPN I-LF
5953
+ Open PROPN I-LF
5954
+ Data PROPN I-LF
5955
+ Access PROPN I-LF
5956
+ ( PUNCT O
5957
+ YODA PROPN B-AC
5958
+ ) PUNCT O
5959
+ Project PROPN O
5960
+ and CCONJ O
5961
+ Vivli PROPN O
5962
+ were AUX O
5963
+ created VERB O
5964
+ to PART O
5965
+ facilitate VERB O
5966
+ data NOUN O
5967
+ - PUNCT O
5968
+ sharing NOUN O
5969
+ and CCONJ O
5970
+ to PART O
5971
+ ensure VERB O
5972
+ that SCONJ O
5973
+ clinical ADJ O
5974
+ trial NOUN O
5975
+ data NOUN O
5976
+ are AUX O
5977
+ FAIR PROPN B-AC
5978
+ ( PUNCT O
5979
+ Findable ADJ B-LF
5980
+ , PUNCT I-LF
5981
+ Accessible ADJ I-LF
5982
+ , PUNCT I-LF
5983
+ Interoperable ADJ I-LF
5984
+ and CCONJ I-LF
5985
+ Reusable ADJ I-LF
5986
+ ) PUNCT O
5987
+ [ PUNCT O
5988
+ 5 NUM O
5989
+ ] PUNCT O
5990
+ . PUNCT O
5991
+
5992
+ We PRON O
5993
+ further ADV O
5994
+ analyzed VERB O
5995
+ primary ADJ B-LF
5996
+ human ADJ I-LF
5997
+ monocyte NOUN I-LF
5998
+ - PUNCT I-LF
5999
+ derived VERB I-LF
6000
+ macrophages NOUN I-LF
6001
+ ( PUNCT O
6002
+ PHMDMs PROPN B-AC
6003
+ ) PUNCT O
6004
+ differentiated VERB O
6005
+ from ADP O
6006
+ CD14 NOUN O
6007
+ + NOUN O
6008
+ monocytes NOUN O
6009
+ . PUNCT O
6010
+
6011
+ ISS PROPN O
6012
+ : PUNCT O
6013
+ Injury NOUN O
6014
+ severity NOUN O
6015
+ score NOUN O
6016
+ , PUNCT O
6017
+ ER NOUN B-AC
6018
+ : PUNCT O
6019
+ emergency NOUN B-LF
6020
+ room NOUN I-LF
6021
+ , PUNCT O
6022
+ DM NOUN O
6023
+ : PUNCT O
6024
+ Diabetes NOUN O
6025
+ mellitus NOUN O
6026
+ , PUNCT O
6027
+ SBP NOUN O
6028
+ : PUNCT O
6029
+ Systolic ADJ O
6030
+ blood NOUN O
6031
+ pressure NOUN O
6032
+ , PUNCT O
6033
+ APC NOUN B-AC
6034
+ : PUNCT O
6035
+ Anterior ADJ O
6036
+ - PUNCT O
6037
+ posterior ADJ O
6038
+ compression NOUN O
6039
+ , PUNCT O
6040
+ LC NOUN O
6041
+ : PUNCT O
6042
+ Lateral ADJ O
6043
+ compression NOUN O
6044
+ , PUNCT O
6045
+ VS NOUN O
6046
+ : PUNCT O
6047
+ Vertical ADJ O
6048
+ shear NOUN O
6049
+ . PUNCT O
6050
+
6051
+ As SCONJ O
6052
+ described VERB O
6053
+ below ADV O
6054
+ , PUNCT O
6055
+ we PRON O
6056
+ have AUX O
6057
+ tested VERB O
6058
+ both CCONJ O
6059
+ double ADJ O
6060
+ - PUNCT O
6061
+ stranded ADJ O
6062
+ ( PUNCT O
6063
+ dsDNA NOUN B-AC
6064
+ ) PUNCT O
6065
+ and CCONJ O
6066
+ single ADJ B-LF
6067
+ - PUNCT I-LF
6068
+ stranded ADJ I-LF
6069
+ DNA NOUN I-LF
6070
+ ( PUNCT O
6071
+ ssDNA NOUN B-AC
6072
+ ) PUNCT O
6073
+ using VERB O
6074
+ two NUM O
6075
+ methods NOUN O
6076
+ of ADP O
6077
+ staining VERB O
6078
+ with ADP O
6079
+ fluorophores NOUN O
6080
+ , PUNCT O
6081
+ and CCONJ O
6082
+ we PRON O
6083
+ report VERB O
6084
+ here ADV O
6085
+ the DET O
6086
+ proof NOUN O
6087
+ of ADP O
6088
+ concept NOUN O
6089
+ demonstrating VERB O
6090
+ that SCONJ O
6091
+ ssDNA NOUN B-AC
6092
+ shows VERB O
6093
+ sequence NOUN O
6094
+ - PUNCT O
6095
+ specific ADJ O
6096
+ responses NOUN O
6097
+ to ADP O
6098
+ a DET O
6099
+ variety NOUN O
6100
+ of ADP O
6101
+ volatile ADJ O
6102
+ compounds NOUN O
6103
+ and CCONJ O
6104
+ that SCONJ O
6105
+ libraries NOUN O
6106
+ of ADP O
6107
+ these DET O
6108
+ materials NOUN O
6109
+ can AUX O
6110
+ be AUX O
6111
+ efficiently ADV O
6112
+ screened VERB O
6113
+ for ADP O
6114
+ odor NOUN O
6115
+ responses NOUN O
6116
+ . PUNCT O
6117
+
6118
+ MglA PROPN B-AC
6119
+ is AUX O
6120
+ an DET O
6121
+ ortholog NOUN O
6122
+ of ADP O
6123
+ the DET O
6124
+ stringent ADJ B-LF
6125
+ starvation NOUN I-LF
6126
+ protein NOUN I-LF
6127
+ A PROPN I-LF
6128
+ ( PUNCT O
6129
+ SspA PROPN B-AC
6130
+ ) PUNCT O
6131
+ from ADP O
6132
+ Escherichia PROPN O
6133
+ coli PROPN O
6134
+ ( PUNCT O
6135
+ the DET O
6136
+ two NUM O
6137
+ proteins NOUN O
6138
+ share VERB O
6139
+ 21 NUM O
6140
+ % NOUN O
6141
+ identity NOUN O
6142
+ and CCONJ O
6143
+ 34 NUM O
6144
+ % NOUN O
6145
+ similarity NOUN O
6146
+ at ADP O
6147
+ the DET O
6148
+ primary ADJ O
6149
+ amino NOUN O
6150
+ acid NOUN O
6151
+ level NOUN O
6152
+ ) PUNCT O
6153
+ . PUNCT O
6154
+